Impact of peak intraoperative lactate levels on post-operative outcomes in congenital cardiac surgery by Pretorius, Frans Johannes
  
Impact of peak intraoperative lactate levels on post-
operative outcomes in congenital cardiac surgery 
 
 
FRANS JOHANNES PRETORIUS 
 
 
Dissertation submitted in the fulfilment of the requirements of the degree 
 
MASTER OF HEALTH SCIENCES  
CLINICAL TECHNOLOGY 
 
Department of Health Sciences 
Faculty of Health and Environmental Sciences  
 
Central University of Technology 
Bloemfontein, South Africa 
 
  
Supervisor:  Dr L Botes, D-Tech, (CUT) 
Co-Supervisors: Prof FE Smit, PhD, Assoc. FCS (Cardiothoracic Surgery SA), MBChB MMed (UFS) 
 
 
Bloemfontein        October 2017 
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
 iii       
2.5.3  Systemic inflammatory response syndrome (SIRS)   13 
2.5.4  Electrolyte imbalances       14 
2.5.5  Lactate production leading to hyperlactatemia    15 
2.5.5.1  History of lactate production      16 
2.5.5.2  Physiology and pathophysiology of lactate production   17 
2.5.5.3  Hyperlactatemia        20 
2.5.5.3.1 Predictive factors for hyperlactatemia     22 
2.6  Myocardial protection during cardiac surgery     25 
2.6.1  Clinical mechanisms of myocardial protection    26 
2.6.2  Methods providing myocardial protection during cardiac surgery 26 
2.6.2.1  Hypothermia         26 
2.6.2.2  Cardioplegia         27 
2.7  Postoperative complications and outcomes after CPB surgery  33 
2.7.1  Postoperative complications      33 
2.7.2  Postoperative outcomes       36 
2.7.2.1  Inotropic support        36 
2.7.2.2  Ventilation management       37 
2.7.2.3  ICU stay         38 
 
CHAPTER 3: METHODOLOGY        40 
3.1  Introduction         40 
3.2  Study location        40 
3.3  Study population        40 
3.3.1  Study cohorts         41 
3.3.2  In- and exclusion criteria       41 
3.3.2.1  Inclusion criteria        41 
3.3.2.2  Exclusion criteria        42 
3.4  Study design         42 
3.5  Conceptual framework for data collection     42 
3.5.1  Objective 1 and 2 – Lactate <4mmol/L versus ≥4mmol/L  42 
3.5.2  Sub-objective – St Thomas II versus Bretschneider custodiol  45 
3.6  Special investigations       47 
3.6.1  Preoperative data        47 
© Central University of Technology, Free State
 iv       
3.6.2  Intraoperative data        47 
3.6.2.1  Metabolic data        47 
3.6.2.2  Perfusion and cardioplegia       48 
3.6.2.3  Cardiopulmonary bypass (CPB) surgery     49 
3.6.3  Postoperative data        50 
3.6.3.1  Metabolic data        50 
3.6.3.2  Postoperative clinical outcomes and complications   51 
3.7  Statistical analysis        51 
3.8  Ethical aspects and good clinical practice     51 
3.8.1  Ethical clearance        51 
3.8.2  Good clinical practice (GCP) / quality assurance    52 
3.8.3  Confidentiality         52 
 
CHAPTER 4: RESULTS         53 
4.1  Introduction         53 
4.2  Peak intraoperative lactate <4mmol/L (group 1) versus  
peak intraoperative lactate ≥4mmol/L (group 2)    53 
4.2.1  Demographic and anthropometric data     54 
4.2.1.1  Demographic and anthropometric data: comparison between 
  group 1 and 2         56 
4.2.2  Type of cardiac lesion       56 
4.2.3  Metabolic data        57 
4.2.3.1  Lactate (mmol/L)        58 
4.2.3.2  Haematocrit (%)        59 
4.2.4  Aortic cross-clamp time (min), CPB time (min) and  
oesophageal temperature (°C)      61 
4.2.5  Postoperative complications and clinical outcomes   62 
4.2.5.1  Postoperative complications      62 
4.2.5.2  Postoperative clinical outcomes      64 
4.2.6  Cardioplegic solutions       66 
4.3  St Thomas II versus Bretschneider custodiol cardioplegic 
  solution         66 
4.3.1  Demographic and anthropometric data     67 
© Central University of Technology, Free State
 v       
4.3.1.1  Demographic and anthropometric data: comparison between 
  CPS 1 and 2         69 
4.3.2  Type of cardiac lesion       69 
4.3.3  Metabolic data        70 
4.3.3.1  Lactate (mmol/L)        70 
4.3.3.2  Haematocrit (%)        72 
4.3.3.3  Sodium (mmol/L)        74 
4.3.3.4  Potassium (mmol/L)        76 
4.3.4  Aortic cross-clamp time (min), CPB time (min) and  
oesophageal temperature (°C)      78 
4.3.5  Postoperative complications and clinical outcomes   79 
4.3.5.1  Postoperative complications      79 
4.3.5.2  Postoperative clinical outcomes      81 
 
CHAPTER 5: DISCUSSION         83 
5.1  Introduction         83 
5.2  Peak intraoperative lactate <4mmol/L (group 1) versus  
peak intraoperative lactate ≥4mmol/L (group 2)    84 
5.2.1  Preoperative demographics, anthropometrics and cardiac lesions 84 
5.2.2  Metabolic data        85 
5.2.2.1  Lactate (mmol/L)        85 
5.2.2.2  Haematocrit (%)        86 
5.2.3  Aortic cross-clamp time (min), CPB time (min) and  
oesophageal temperature (°C)      86 
5.2.4  Postoperative complications and clinical outcomes              87 
5.2.5  Cardioplegic solutions                  89 
5.3  St Thomas II versus Bretschneider custodiol cardioplegia             90 
5.3.1  Preoperative demographics, anthropometrics and cardiac lesions        90 
5.3.2  Metabolic data                   91 
5.3.2.1  Lactate (mmol/L)                  91 
5.3.2.2  Haematocrit (%)                  92 
5.3.2.3  Sodium (mmol/L)                   92 
5.3.2.4  Potassium (mmol/L)                   93 
© Central University of Technology, Free State
 vi       
5.3.3  Aortic cross-clamp time (min), CPB time (min) and  
oesophageal temperature (°C)                 93 
5.3.4  Postoperative complications and clinical outcomes              94 
 
CHAPTER 6: CONCLUSION                    97 
6.1  Introduction                    97 
6.2  Peak intraoperative lactate values as a predictor of postoperative 
  outcomes                    98 
6.3  Cardioplegia as a predictor of postoperative outcomes              99 
6.4  Limitations                   100 
6.5  Recommendations                  100 
 
CHAPTER 7: REFERENCES                   101 
 
APPENDICES                     132 
Appendix A Ethics approval                  133 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
 ix       
e.g.   example 
ECG   electrocardiogram 
FDA   food and drug administration 
FRC   functional residual capacity 
g   gram 
GCP   good clinical practice 
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using chemical, cold (cryocardioplegia), or electrical 
stimulation (Medicinenet, 2017). 
Complications An unanticipated problem that arises following, and is result 
of, a procedure, treatment, or illness. A complication is so 
named because it complicated the situation (Medicinenet, 
2017). 
Hemodynamics Hemodynamics is the study of all parameters influencing 
blood flow or circulation (Merriam-Webster, 2017). 
Hyperlactatemia Is a persistent, mild to moderate (2-4mmol/L) increase in 
blood lactate concentration without metabolic acidosis, 
whereas lactic acidosis is characterized by persistently 
increased blood lactate levels (usually >5mmol/L) in 
association with metabolic acidosis (Gunnerson, 2017). 
Hypoperfusion Decreased blood flow through an organ, consequently there 
is a decrease in oxygen delivery. If hypoperfusion is 
prolonged it may cause cellular dysfunction and even death 
(Merriam-Webster, 2017). 
Inflammation A local response to cellular injury that is marked by capillary 
dilatation, leukocyte infiltration, redness, heat, and pain that 
serves as a mechanism initiating the elimination of noxious 
agents and damaged tissue (Merriam-Webster, 2017). 
Metabolic Relating to metabolism, the whole range of biochemical 
processes that occur within us (or any living organism). 
Metabolism consists of anabolism (the build-up of 
substances) and catabolism (the breakdown of substances) 
(Medicinenet, 2017). 
Morbidity Loss of physical or psychological well-being, resulting from 
disease, illness, injury, or sickness, especially where the 
affected individual is aware of their own state (Merriam-
Webster, 2017). 
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Mortality The state or condition of being subjected to death, a fatal 
outcome (Merriam-Webster, 2017). 
Neonate A new-born baby, specifically a baby in the first 4 weeks after 
birth. After a month, a baby is no longer considered a neonate 
(Medicinenet, 2017). 
Paediatrics The field of medicine that is concerned with the health of 
infants, children, and adolescents; their growth and 
development; and their opportunity to achieve full potential 
as adults (Medicinenet, 2017). 
Pathophysiology The physiology of abnormal states; specifically: the 
functional changes that accompany a syndrome or disease 
(Medicinenet, 2017). 
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Thomas II cardioplegic solution and CPS 2 patients that received Bretschneider custodiol 
cardioplegic solution.  For both analyses the demographic, anthropometric, clinical, 
intraoperative and postoperative complications and outcomes were recorded for each 
group and compared. 
 
Results 
Group 1 (n=52) and 2 (n=44) were created based on high and low lactate values, 
therefore, it is no surprise that statistical significance is present intraoperatively between 
the two (2) groups (p<0.05).  The patients in group 2 were younger (median 2.4 months) 
compared to the patients in group 1 (median 14.5 months) at the time of surgery.  
Postoperatively, the lactate levels in group 1 was significantly lower compared to group 
2, however, at 48h post-CPB both groups had normal mean lactate values of <2mmol/L.  
Intraoperatively, the aortic cross-clamp time and total bypass time were longer in group 
2 (144.5 min; 221.4 min) compared to group 1 (125.3 min; 178.1).  Postoperative 
complications were reported for both group 1 and 2 but only wound/sternal dehiscence 
(p=0.0208) and sternum left open (p=0.0157) showed statistical significant differences 
between the two (2) groups.  No statistical significant differences were reported for 
mortality and postoperative outcomes between the two (2) groups. 
 
The patients receiving CPS 2 (n=37) were younger (p<0.0001), weigh less (p=0.0004) 
and were shorter (0.0003) compared to the patients receiving CPS 1 (n=59).  
Intraoperatively, CPS 2 had higher lactate values (p=0.0332) lower sodium values 
(p<0.0001) and a longer total bypass time (p=0.0328) compared to CPS 1.  
Postoperatively, the only statistical significant differences between CPS 1 and CPS 2 were 
recorded for phrenic or recurrent laryngeal nerve (RLN) injury (p=0.0199) and new 
onset seizures (p=0.0199).  Patients receiving CPS 2 had a higher incidence of both 
phrenic or recurrent laryngeal nerve injury and new onset seizures.  No statistical 
significant differences were reported for mortality and postoperative outcomes between 
the two (2) groups. 
 
Discussion 
Postoperative complications were reported for both lactate groups but limited statistical 
significant differences were recorded between patients with peak intraoperative lactate 
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levels 4mmol/L versus those with lactate levels <4mmol/L.  In this study, assessing 
lactate levels at a single point intraoperatively did not correlate with postoperative 
complications or mortality.  Reason being, the absolute peak intraoperative lactate value 
of 4mmol/L was probably too low to demonstrate an association between 
hyperlactatemia as a predictor for increased postoperative clinical outcomes and 
complications.  In addition, in our unit any intraoperative increase in lactate levels above 
2.5mmol/L prompts the need for therapeutic interventions. 
 
The only statistical difference between the two cardioplegia groups were for new onset 
seizures and phrenic or recurrent laryngeal nerve injury.  Associations between these 
injuries and the use of Bretschneider custodiol cardioplegia has already been published.  
No substantial differences were found between St Thomas II and Bretschneider custodiol 
cardioplegia with regard to other postoperative complications, clinical outcomes and 
mortality. 
 
Conclusion 
Therefore, in this study increased postoperative complications and outcomes were not 
associated with patients with an intraoperative peak lactate value ≥4mmol/L and no 
clear association could be made between the use of cardioplegic solutions as a predictor 
of postoperative complications and outcomes. 
© Central University of Technology, Free State
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 2 Introduction 
include cardiac, renal, pulmonary, neurological and infectious complications to name just 
a few (Vijarnsorn et al., 2012; Agarwal et al., 2011).  Furthermore, the time spend on CPB 
during paediatric cardiac surgery is associated with longer Intensive Care Unit (ICU) 
stays, increased intubation times, and increased mortality (Agarwal et al., 2014; Agarwal 
et al., 2011). 
 
Hyperlactatemia, intraoperatively has been associated with the development of 
postoperative complications and outcomes.  About 10-20% of cardiac patients develop 
hyperlactatemia during cardiac surgery and the severity thereof is associated with an 
increased morbidity and mortality.  Therefore, hyperlactatemia has been used as a 
marker to predict postoperative outcome in children during and after cardiac surgery 
(Siegel et al., 1996). 
 
During paediatric cardiac surgery hyperlactatemia reflects tissue malperfusion and 
cellular hypoxia (Siegel et al., 1996).  However, the aetiology of hyperlactatemia during 
cardiac surgery is still controversial but many authors tend to attribute hyperlactatemia 
to tissue hypoxia (type A hyperlactatemia) and to type B hyperlactatemia (without tissue 
hypoxia).  Although hyperlactatemia can be used as a predictor of morbidity and 
mortality in cardiac surgery it is important to consider that the initial stimulus for lactate 
production may occur during CPB.  Type A hyperlactatemia is characterized by impaired 
tissue oxygenation which leads to an increased anaerobic metabolism and the excessive 
production of pyruvate which is then converted into lactate that can result in lactic 
acidosis.  Type B hyperlactatemia is characterized by an increased or impaired cellular 
metabolism that can be initiated due to the inactivation of pyruvate dehydrogenase or 
due to drug-induced mitochondrial dysfunction.  Type B hyperlactatemia is frequently 
seen in the early postoperative period after cardiac surgery (Yilmaz et al., 2011; Livesey, 
2006; Maillet et al., 2003).  
 
An elevated serum plasma lactate level is common in paediatric CHD at the time the 
patient is admitted to ICU after cardiac surgery.  However, the patient must reach normal 
lactate levels within 24 hours (Hr) after being admitted to ICU, if not it is associated with 
an increase in morbidity and mortality (Molina-Hazan and Paret, 2014). 
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The use of serum lactate levels to predict adverse outcomes in intensive care settings are 
well defined (Perfecto et al., 2012; Shime et al., 2001). Different lactate cut-off values are 
assigned to different patient groups to predict adverse clinical outcomes and even death 
(Perfecto et al., 2012; Shime et al., 2001).  However, the value of peak intraoperative 
lactate levels in cardiac surgery to predict clinical outcomes is still controversial because 
of discrepancies regarding reference intervals (3-6mmol/L), cut-off points, time and 
whether single or multiple lactate measurements should be considered (Kanazawa et al., 
2015).  Increased (peak) lactate levels may be an indication of low cardiac output or 
reduced tissue oxygen extraction but perhaps the change in lactate over time is a more 
reliable marker of a response to therapeutic interventions and subsequent clinical 
outcomes.  In cardiac surgery, no specific lactate level has been identified as a consistent 
indicator of adverse clinical outcomes (Molina-Hazan and Paret, 2014; Molina-Hazan et 
al., 2010). 
 
Therefore, the aim of this study was to evaluate whether an association exists between 
peak intraoperative blood lactate levels ≥4mmol/L and increased postoperative 
complications and outcomes in paediatric CHD patients receiving CPB surgery. 
 
1.1 Aim 
 
To evaluate the impact of peak intra-operative lactate values on post-operative 
complications and outcomes in CHD patients receiving CPB. 
 
1.2 Objective 
 
1.) To evaluate whether a peak intraoperative lactate level ≥4mmol/L is associated 
with increased postoperative complications [complications as listed in Society of 
Thoracic Surgery (STS) database]. 
 
2.) To evaluate whether a peak intraoperative lactate level ≥4mmol/L is associated 
with increased postoperative outcomes (length of inotropic support, ventilation 
time, time spend in ICU). 
© Central University of Technology, Free State
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1.2.1 Sub-objective 
 
As a sub-objective of the study the patients were divided based on the cardioplegic 
solution used during CPB and not divided based on peak intraoperative lactate values. 
Due to the fact that this was a retrospective study the variables that could influence the 
results with regard to the use of cardioplegia was not standardized. Hence, the reason 
why this analysis was only regarded as a sub-objective. 
 
Therefore, the sub-objective was to evaluate whether the use of St Thomas hospital II 
cardioplegia or Bretschneider custodiol cardioplegia is associated with increase 
postoperative complications (STS Database) and outcomes (length of inotropic support, 
ventilation time, time spend in ICU) in CHD children receiving CPB. 
 
© Central University of Technology, Free State
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2.2 Aetiology of congenital heart disease 
 
In vertebrates, embryonic development of the heart starts at day fifteen (15) and 
comprise an organized series of molecular and morphologic events that involve five (5) 
primary steps (Gittenberger-de Groot et al., 2005; Moorman and Christoffels, 2003; 
McFadden and Olson, 2002): 
 
a. Pre-cardiac cell migration from the primitive streak and assembly of the paired 
cardiac crescents at the myocardial plate 
b. Coalescence of the cardiac crescents to form the primitive heart tube, 
establishment of the definitive heart 
c. Cardiac looping, assurance of proper alignment of the future cardiac chambers 
d. Septation and heart chamber formation 
e. Development of the cardiac conduction system and coronary vasculature 
 
The development of each component occurs at specified time intervals under the 
orchestration of a cascade of genes and gene products resulting in a series of complex 
processes coordinating cell migration and extracellular matrix formation (Gittenberger-
de Groot et al., 2005). Therefore, CHD is generally the result of an alteration in the 
development of the embryonic structure, or a failure of the structure to develop beyond 
an early embryonic or foetal stage. Further structural and functional developments are 
generally influenced by the anatomical defect.  Even though descriptions of abnormal 
heart development in foetuses and babies have remained unclear, considerable advances 
in the knowledge about CHD aetiology have been made during the last decade (Sayasathid 
et al., 2015; Bax et al., 2010).  
 
Some cardiac malformations may be associated with the consequences of exposure to 
environmental toxins or diets, or may be directly inherited through vertical gene transfer, 
thus a genetic disorder (Lander, 2011).  Alternatively, it is also possible that random 
errors in cell migration leading to improper cardiac development can result in CHD. 
Together, these findings emphasize the complex and multifactorial causes of CHD and 
warrants the need for future research (Sayasathid et al., 2015). 
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2.3 Classification of congenital heart disease 
 
Congenital heart defects may be classified as acyanotic or cyanotic depending on whether 
the patients clinical picture exhibit signs of cyanosis. Acyanotic lesions can be further 
divided into left-to-right shunts and obstructive lesions and by definition, cyanotic 
lesions present as right-to-left shunts (Rao, 2015; Thiene and Frescura, 2010). 
 
2.3.1 Acyanotic heart defects 
 
2.3.1.1 Obstructive lesions 
 
A significant narrowing of a blood vessel or a valve result in increased pressure proximal 
to the obstruction in comparison to the pressure distal to the obstructed vessel or valve.  
However, this pressure gradient is necessary to maintain flow across the stenotic area.  
The clinical presentation of the patient will be determined by the degree of hypertrophy 
of the cardiac chamber proximal to the obstruction and flow disturbances across the area 
of obstruction and their effects (Rao, 2015; Thiene and Frescura, 2010).  
 
2.3.1.2 Left-to-right shunts 
 
A defect in the partition between the left and right heart structures result in oxygenated 
blood being shunted from left-to-right because of normally lower pressure and/or 
resistance in the right heart than the left heart.  The physical findings are either a sign of 
flow across the defects or due to effects of excessive flow across the cardiac chambers 
(volume overload) and valves. The clinical presentation and symptoms of the patients are 
determined by the magnitude of the shunt (Rao, 2015; Thiene and Frescura, 2010). 
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2.3.2 Cyanotic heart defects 
 
2.3.2.1 Right-to-left shunts 
 
Cyanotic heart defects can be described as systemic venous blood that bypasses the 
pulmonary circulation and gets shunted across into the left side of the heart resulting in 
systemic arterial desaturation. Cyanotic CHD does not include pulmonary venous 
desaturation secondary to congestive heart failure and cyanosis due to intrapulmonary 
right-to-left shunting.  Obstruction to pulmonary blood flow, parallel rather than in-series 
circulation, and complete admixture of pulmonary and systemic venous returns are the 
causes of right-to-left shunts and cyanosis (Rao, 2015; Thiene and Frescura, 2010). 
 
2.4 Treatment procedures for congenital heart disease  
 
Many children living with a congenital heart defect do not need treatment, but some do 
(National Heart, Lung, and Blood Institute, 2015).  The treatment options available to 
treat CHD includes catheter procedures or open-heart surgery.  In some cases, catheter 
and surgical procedures are combined to repair complex heart defects (National Heart, 
Lung, and Blood Institute, 2015; Gaca et al., 2008). 
 
The type and severity of the child’s defect will determine the choice of treatment (Gaca et 
al., 2008).  Other factors influencing the choice of treatment include age, size and the 
general health of the child (National Heart, Lung, and Blood Institute, 2015; Gaca et al., 
2008).  Some children with complex CHD may need numerous catheter or surgical 
procedures over a period of time (years) (National Heart, Lung, and Blood Institute, 
2015). 
 
2.4.1 Catheter procedures 
 
Catheter procedures put less stress on patients than open-heart surgery (Fuchs et al., 
2015).  It only involves a needle puncture to the skin and the catheter is inserted either 
© Central University of Technology, Free State
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into a vein or an artery.  There is no need to surgically open the chest of the patient or to 
operate directly on the heart.  This results in a faster and easier recovery period for the 
patient (Fuchs et al., 2015; National Heart, Lung, and Blood Institute, 2015).  Catheter 
procedures have become the preferred method to repair many simple heart defects, such 
as atrial septal defects (ASD) and pulmonary valve stenosis (Fuchs et al., 2015; National 
Heart, Lung, and Blood Institute, 2015).  However, unfortunately not all lesions can be 
repaired via catheter procedures and warrants open-heart surgery. 
 
2.4.2 Open-heart surgery 
 
The surgical treatment used for CHD in paediatric patients are referred to as open-heart 
surgery using CPB (Jaggers and Ungerleider, 2006).  The first corrective surgery with CPB 
for intra-cardiac malformations was performed in 1950 at the Mayo Clinic, University of 
Minnesota, United States (US) (Lillehei et al., 1956). 
 
The surgeon makes an incision through the breastbone (sternum) while the child is under 
general anaesthesia.  The surgeon then places cannulas in the heart to connect the patient 
to the heart-lung machine.  The physiologic effects of open-heart surgery with CPB on 
neonates, infants and paediatric patients are significantly different than the effects on 
adults (Rao, 2015; Gaca et al., 2008; Jaggers and Ungerleider, 2006).  During open-heart 
surgery, the paediatric patients are exposed to biological extremes not seen in adults, 
including haemodilution, deep hypothermia, low perfusion pressures, wide variation in 
pump flow rates and different blood pH management techniques (Jaggers and 
Ungerleider, 2006).  All these factors contribute to the possibility of these children 
developing complications not only intraoperative but also postoperative. 
 
For this study emphasis will be placed on open-heart surgery as treatment modality for 
the repair of CHD in infants. 
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2.5 Cardiopulmonary bypass (CPB) and associated 
complications 
 
CPB refers to the heart and lungs being bypassed, during open-heart surgery. Blood is 
diverted to and through a heart-lung machine as it returns to the heart; the heart-lung 
machine oxygenates the blood before returning it to the patient’s arterial circulation. The 
oxygenation is achieved through membrane oxygenation which acts like the lungs 
(Machin and Allsager, 2006). The heart-lung machine does the work of the heart (by 
pumping the blood), and the lungs (supplying oxygen and removing carbon dioxide from 
the red blood cells) (Sandham, 2014; Machin and Allsager, 2006). 
 
CPB remains a non-physiological procedure despite significant improvements; the effects 
of altered perfusion, hypothermia, embolization, haemodilution, acid-base management, 
and the systemic inflammatory response have been challenging, particularly in neonates 
and infants. The smaller circulatory volume, increased capillary membrane permeability, 
and the immaturity of most organ systems in neonates and infants are primarily related 
to these challenges (Jones and Elliot, 2006; Jonas et al., 2003). 
 
The correction of congenital cardiac defects in paediatric patients with the use of CPB has 
a profound physiologic effect on most organ systems of the body (Giacomuzzi et al., 
2008). These physiological effects include, alterations in the normal concentrations of 
formed blood elements, plasma proteins and activation of the humoral cascade systems; 
alterations in the normal concentration of fluid and electrolyte balances; effects on the 
central nervous system (CNS); alterations to the renal system; effects on the splanchnic, 
visceral and hepatic systems; effects on the pulmonary system; inflammatory and 
immunological responses; endocrine, metabolic, and stress responses; and, probably 
most importantly, the myocardium in the form of myocardial ischemia (Hessel et al., 
2013). Paediatric cardiac procedures with CPB often require extremely low temperatures 
and perfusion flow rates, and therefore, haemodilution. 
 
Surgical techniques are constantly being refined to limit the time spent on CPB or in deep 
hypothermic circulatory arrest (DHCA) (Onuzo, 2006).  Therefore, although CPB is still 
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an essential assisting method for open-heart surgery it remains one of the most 
important factors linked to postoperative mortality and morbidity in open-heart surgery 
(Wang et al., 2011).  Some of the most important complications encountered during open-
heart surgery is summarized below. 
 
2.5.1 Myocardial damage 
 
Advances in paediatric cardiac surgery were accompanied by improvements in CPB 
technology leading to significant improvements in surgical outcomes (Vakamudi et al., 
2012; Bronicki and Chang, 2011; Hasegawa et al., 2005). However, perioperative 
myocardial damage remains the most common cause of morbidity and mortality after 
successful surgical correction. A study conducted by Hasegawa et al. (2005) reported that 
the younger the patient, the more susceptible the myocardium is to injury caused by 
ischemia during definitive repair of CHD. Consequently, perioperative care for paediatric 
patients with CHD need to take into consideration the dependence of the myocardial 
damage on age and ischemic time (Vakamudi et al., 2012; Hasegawa et al., 2005).   
 
Myocardial cell damage in infants exposed to open-heart surgery can directly be 
associated with varying combinations of histo-chemical, microscopic, and gross 
myocardial necrosis in up to 90% of patients who do not survive the perioperative period 
(Daniels, 2008). The observed modifications within the myocardium can potentially be 
attributed to the heart anomaly itself, preoperative hemodynamic instability and its 
treatment, cardiopulmonary bypass, myocardial protection strategies, surgical 
techniques, and postoperative medical care (Daniels, 2008). 
 
In addition, patients with CHD are at increased risk of developing myocardial ischemia or 
premature coronary artery disease (CAD). The increased risk is a result of: 
 
• Congenital coronary artery abnormalities  
• Previous cardiac surgery 
• Myocardial ischemia which is not directly related to coronary artery anomalies 
but presenting after an arterial switch operation for transposition of the great 
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arteries (TGA) and in patients with a congenital corrected transposition of the 
great arteries (ccTGA) (Daniels, 2008) 
 
It is generally accepted that the immature heart has a greater tendency to tolerate 
ischemia than the mature heart, most of this is based on laboratory data acquired from 
normal hearts (Jaggers and Ungerleider, 2006). With pre-existing conditions such as 
hypertrophy, cyanosis, or acidosis, it is unclear what the ischemic tolerance is. In 
neonates and infants who require surgical correction of heart defects. Many of these pre-
existing conditions may be present and may compromise myocardial protection (Jaggers 
and Ungerleider, 2006).   
 
During CPB the hypoxic conditions and the ischemic effects can affect cardiomyocytes by 
inducing rapid or gradual injury to the membrane systems (Asano et al., 2003). 
 
The reperfusion of the myocardium also has negative consequences during circulatory 
interruption (Buckberg and Allen, 1995; Follette et al., 1981).  Interrupted coronary 
circulation is required in nearly all cardiac surgeries and the potential for reperfusion 
damage is considerable.  The initial damage caused by a reperfusion injury may 
contribute to impaired cardiac performance that develops immediately after surgery 
possibly leading to myocardial fibrosis (Castañeda et al., 1994; Kirklin and Barratt-Boyes, 
1993).  Therefore, myocardial protection during surgically induced myocardial ischemia 
is important.  Hypothermic cardioplegia is the method of choice for myocardial protection 
(Mayer, 1998).  Incomplete myocardial protection during surgically induced myocardial 
ischemia has a prominent effect on postoperative surgical outcomes, including low 
cardiac output, requirements for increased inotropic support, and elevated atrial filling 
pressures (Mayer, 1998). 
 
During CPB the surgeon cross-clamp the aorta to allow for intervention on the aortic root, 
the aortic valve, and the left ventricular outflow tract (LVOT).  Myocardial perfusion is 
retrograde during CPB; therefore, during the aortic cross clamping the heart is stopped 
and is not perfused (Hirleman and Larson, 2008; Jaggers and Ungerleider, 2006; Mayer, 
1998).  Long aortic cross-clamp times therefore are, thus a likely cause of ischemic injury 
to the heart. 
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2.5.2 Haemodilution 
 
Haemodilution during CPB was introduced in the 1950s to decrease the use of 
homologous blood (Neptune et al., 1960) and has been thought to improve 
microcirculatory flow (Cooper and Slogoff, 1993).  However, haemodilution may also 
reduce perfusion pressure, which increases the risk of an adverse neurological outcome 
after CPB (Murphy et al., 2009; Jonas et al., 2003; Gold et al., 1995).  Additionally, 
haemodilution increases cerebral blood flow (Murphy et al., 2009; Jonas et al., 2003; 
Sungurtekin et al., 1999) and in doing so might increase the microembolic load to the 
brain (Newburger and Bellinger, 2006; Nollert and Reichart, 2001).  Lastly, 
haemodilution reduces the oxygen carrying capacity of blood; in combination with the 
leftward shift of oxyhaemoglobin dissociation induced by hypothermia. This condition 
might be aggravated using an alkaline pH strategy.   
 
Experience with cardiovascular surgery in adults refusing blood transfusions suggests 
that very low haematocrit levels can be tolerated (Murphy et al., 2009; Cooper, 1990).  
The optimal haematocrit level for cerebral protection during hypothermic CPB has not 
been defined.  Published expert opinions (Murphy et al., 2009; Hammon et al., 2001) 
proposed that haematocrit levels of greater than 15% to 20% are safe during CPB in 
adults. 
 
Several studies have found that the severity of haemodilution during CPB correlates 
strongly with increased perioperative morbidity and/or mortality (Murphy et al., 2009; 
Habib et al., 2005; Karkouti et al., 2005; Habib et al., 2003; Jonas et al., 2003; Fang et al., 
1997). Habib et al. (2005) found that haematocrit levels lower than 22 is associated with 
an increased risk for cardiac and renal complications, sepsis, prolonged ventilation, and 
longer ICU stays. 
 
2.5.3 Systemic Inflammatory Response Syndrome (SIRS) 
 
SIRS is common after cardiac surgery for CHD (Brix-Christensen, 2001).  SIRS is 
characterized by the release of proinflammatory cytokines, but the mechanisms initiating 
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this cascade remain ill defined (Stocker et al., 2004).  The systemic inflammatory 
response is mainly triggered by the generation of shear forces from roller pumps driving 
blood through the bypass circuit, hypothermia as blood is expelled through the 
extracorporeal circuit, surgical trauma, ischemia and contact activation of plasma protein 
systems as circulating blood is exposed to artificial surfaces in the bypass circuit 
(Larmann and Theilmeier, 2004).   
 
CPB also initiates profound physiological alterations which include: 
 
• Blood is in direct contact with large artificial surfaces 
• Pulsatile flow is converted to laminar flow 
• Exposure of the heart to global ischemia with cardioplegic protection 
• The body temperature is lowered by several degrees (Larmann and Theilmeier, 
2004) 
 
These alterations activate the inflammatory response by activating the endothelium, 
platelets, complement system, leukocytes and the coagulation cascade. Surgical trauma 
itself also contributes to the inflammatory response present after surgery (Larmann and 
Theilmeier, 2004).   
 
2.5.4 Electrolyte imbalances 
 
Electrolytes such as potassium, magnesium, calcium and phosphate play important roles 
in cellular metabolism and energy transformation and contribute in the regulation of 
cellular membrane potentials, especially those of muscle and nerve cells (Polderman and 
Girbes, 2004).  Depletion of these electrolytes can induce a wide range of clinical 
disorders, including neuromuscular dysfunction and severe arrhythmias.  The risk for 
these disorders increases significantly when more than one electrolyte is deficient and 
increases still further in the presence of ischaemic heart disease (Ducceschi et al., 2000). 
 
Electrolyte disturbances during cardiac surgery are common. Polderman et al. (2004) 
measured the levels of sodium, potassium, calcium, magnesium, and phosphate in 500 
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consecutive patients undergoing cardiac surgery with CPB.  Despite receiving a 
cardioplegic solution containing potassium and magnesium as well as supplemental 
intravenous potassium and magnesium as required intraoperatively, all electrolyte levels 
decreased significantly when compared with 250 patients admitted to the ICU after other 
major surgical procedures.  Eighty-eight percent of the cardiac patients met the criteria 
for clinical deficiency in one or more electrolytes as compared with 20% of control 
subjects. The study authors speculated that the mechanism for electrolyte loss was likely 
a combination of increased urinary excretion and an intracellular shift. However, it 
should be noted that all cardiac patients received low-dose dopamine, which may have 
enhanced any urinary electrolyte loss. 
 
Intraoperative disturbances in sodium have been shown to be a predictor of 
postoperative delirium (Fitzsimons and Agnihotri, 2007).  Potassium management is 
important not only for weaning from CPB, but also to reduce the incidence of 
postoperative dysrhythmias (Young, 2012).  Mild intraoperative hypocalcaemia is 
common and are usually the cause of haemodilution, binding to citrate in transfused 
blood, binding to albumin, and because of hypomagnesemia (Young, 2012).  
Hypomagnesemia can contribute to several adverse hemodynamic consequences which 
include cardiac arrhythmias, hypertension, and coronary vasoconstriction (Kimura et al., 
1989). 
 
2.5.5 Lactate production leading to hyperlactatemia 
 
According to literature several intraoperative parameters can influence a patients’ peri- 
or postoperative outcome e.g. age, oxygen supply and demand, mean arterial blood 
pressure, bypass flow rates, type of flow (pulsatile versus non-pulsatile), haematocrit 
(Hct), haemodilution, systemic oxygen delivery, Na+, K+, lactate, temperature, acid-base 
management, myocardial protection, CPB time, aortic cross-clamp time, genetic factors, 
neurodegenerative disorders, and comorbidities such as systemic hypertension, chronic 
kidney disease, and diabetes mellitus (Murphy et al., 2009; Lelis and Auler Junior, 2004). 
Hyperlactatemia during cardiac surgery is a common complication encountered during 
cardiac surgery and warrants therapeutic intervention (Oguz et al., 2014). 
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For this study emphasis will be placed on increased intraoperative lactate levels as a 
predictor of postoperative complications and outcomes in CHD children receiving CPB.  
 
Elevated blood lactate levels are not clearly and universally defined but most studies use 
cut-offs between 2.0-2.5mmol/L (Kruse et al., 2011), whereas “high” lactate has been 
defined as a lactate level of >4mmol/L in several studies (Callaway et al., 2009; Howell et 
al., 2007; Shapiro et al., 2005). Additionally, the “normal value” may vary depending on 
the analyses used. The terms lactic acid and lactate are often used interchangeably but 
lactate (the constituent measured in blood) is strictly a weak base whereas lactic acid is 
the corresponding acid. “Lactic acidosis” is often used clinically to describe elevated 
lactate but should be reserved for cases where there is a corresponding acidosis 
(pH<7.35) (Luft et al., 1983). 
 
2.5.5.1 History of lactate production 
 
Berzelius first described lactate in 1807 when he discovered it in its modified form in 
meat juices (Siegel et al., 1996). Lactic acidosis in the setting of severe illness dates back 
in history to the 1800s when Johann Joseph Scherer first measured lactic acid levels in 
post-mortem blood from two females dying of puerperal fever. In 1858, Folwarczny 
described elevated lactate levels in living patients with leukaemia (Kompanje et al., 2007) 
followed by Salomon in 1878, who observed increased lactate levels in patients with 
pneumonia, solid tumours, chronic obstructive pulmonary disease, and congestive heart 
failure (Kompanje et al., 2007). Several years later, Fletcher described how skeletal 
muscles produces lactic acid under anaerobic conditions, noting that when oxygen was 
readily available, it “either restrains by some guidance of chemical event the yield of acid 
in the muscle, or can remove it after its production” (Fletcher, 1907). 
 
Lactate has been used as a marker of tissue malperfusion and cellular hypoxia, and 
hyperlactatemia has been associated with postoperative complications and mortality. In 
clinical practice, lactate levels are often used as a surrogate for illness severity and to 
gauge response to therapeutic interventions (Andersen et al., 2013; Koliski et al., 2005).  
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Particularly, high blood lactate concentrations have been associated with increased 
morbidity and mortality in paediatric patients after cardiac operations (Siegel et al., 
1996).  
 
Blood lactate concentrations are more easily obtained and measured than other 
monitoring variables. Blood lactate levels used as a clinical prognostic tool was first 
suggested in 1964 by Broder and Weil when they observed that a lactate excess of 
>4mmol/L was associated with poor outcomes in patients with undifferentiated shock 
(Broder and Weil, 1964). The use of blood lactate concentrations as a clinical endpoint 
has been studied in surgical, septic, trauma, and critical ill patients (Andersen et al., 2013; 
Koliski et al., 2005). 
 
2.5.5.2 Physiology and pathophysiology of lactate production 
 
Lactate is a glycolytic product that is either used within the cells or transported through 
the plural interstitial and vasculature to nearby and anatomically distributed cells for 
utilization. As such, lactate is a quantitatively important oxidizable substrate and 
gluconeogenetic precursor, and a means by which metabolism in different tissues are 
coordinated (Brooks, 2002; Stacpoole et al., 1994). Furthermore, lactate measurements 
in the critically ill can provide information on illness severity and prognosis.  High blood 
lactate levels are usually, but not always, the result of anaerobic metabolism, particularly 
when it’s associated with metabolic acidosis (Handy, 2006).  
 
The metabolism of pyruvic acid results in the production of lactic acid, a reaction that is 
catalysed by lactate dehydrogenase and one that involves the conversion of NADH into 
NAD+ (reduced and oxidized nicotine adenine dinucleotide, respectively) (Phypers, 2006; 
Philp et al., 2005). Under anaerobic conditions, lactate is a product of glycolysis and feeds 
into the Cori cycle as a substrate for gluconeogenesis (Figure 2.1) (Philp et al., 2005; 
Bellomo, 2002). The pyruvate is converted by lactate dehydrogenase (LDH) to lactic acid. 
In aerobic conditions, the pyruvate is converted to acetyl coenzyme A (CoA) to enter the 
Kreb’s cycle, largely bypassing the production of lactate. Lactic acid dissociates almost 
completely to lactate and H+b in aqueous solutions (Phypers, 2006). Once believed that 
the lack of oxygen in contracting skeletal muscles are the consequence of lactate 
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production, it is now known that lactate is also formed and utilized continuously under 
aerobic conditions (Brooks, 2002).  
 
 
Figure 2.1 Aerobic and anaerobic metabolism (adapted from Andersen et al., 2013) 
 
Normal basal lactate production is 0.8mmol/kg/hour (1300mmol/day) and normal 
plasma lactate concentration is 0.3-1.3mmol/L (3-12mg/dL) (Levy, 2006; Phypers, 
2006).  Normal subjects produce lactic acid between 15-20mmol/kg/day, most of which 
is generated in skeletal muscle, skin, intestine, brain, and red blood cells, either from 
glucose via the glycolytic pathway or from the deamination of alanine (Levy, 2006; 
Huckabee, 1961).  During intense exertion or severe illness its concentration can rise to 
over 20mmol/L (180 mg/dL) (Mizock and Falk, 1992).   
 
Lactate production occurs in many other tissues during severe illness, for example during 
acute lung injury (De Backer et al., 1997).  The splanchnic organs, such as the intestines 
and liver, are another potential source of lactate production and can be predominantly 
vulnerable to inconsistent vasoconstriction in low perfusion states. Whether this 
mechanism contributes to elevated gut lactate in sepsis remains controversial (De Backer 
et al., 2001). During phagocytosis, leukocytes can also produce large amounts of lactate 
(Borregaard and Herlin, 1982). 
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In nature, lactate has two chemical isomers L-lactate and D-lactate. L-lactate is because 
of anaerobic glycolysis in humans and has been used as a marker of tissue malperfusion 
and cellular hypoxia. L-lactate can only be produced or consumed from pyruvate via the 
enzyme LDH in the cytosol, by means of a process of fermentation during normal 
metabolism and exercise (Mizock, 1989). The concentration does not increase until the 
rate of lactate production exceeds the rate of lactate removal, a process which is governed 
by numerous factors (Andersen et al., 2013). D-lactate, is produced from large amounts 
of unabsorbed carbohydrates by bacteria in the human colon. In the setting of varying 
degrees of intestinal flora and a high carbohydrate load (such as in short bowel 
syndrome) there will be an excess production of D-lactate, which can cross into the 
bloodstream and potentially cause neurological symptoms (Petersen, 2005). The D 
isomer is mostly exogenous from Ringer’s lactate solution infusion, and its non-iatrogenic 
presence in humans is uncommon. Its clearance is much slower than L-lactate, with the 
clearance mainly dependent on liver function (Uribarri et al., 1998). 
 
Tissue sources of lactate production include perivenous hepatocytes, skeletal myocytes, 
erythrocytes and skin with the highest production found in skeletal muscles (Van Hall, 
2010; Consoli et al., 1990). The liver is the major organ of lactate utilization, followed by 
the kidneys (Levraut et al., 1998; Consoli et al., 1990; Mizock, 1989; Connor et al., 1982; 
Huckabee, 1961). About 70% of lactate is removed by the liver and less than 5% of lactate 
is renally excreted. In the liver, lactate uptake involves both a monocarboxylate 
transporter and the less efficient process of diffusion, while renal fraction may increase 
and become more clinically significant during hyperlactatemia (Phypers, 2006; Levraut 
et al., 1998). 
 
The pathophysiology in various disease conditions resulting in elevated lactate levels is 
likely multifactorial, disease-specific, and patient-specific.  In general, elevated lactate can 
be caused by increased production, decreased clearance, or a combination of both. 
Elevated lactate’s aetiology is perhaps best studied in shock states (Donnino et al., 2010; 
Jones and Puskarich, 2009; Trzeciak et al., 2007; James et al., 1999; Gore et al., 1996; Rady, 
1992).  Contributing factors appear to include: mitochondrial dysfunction (including 
potential lack of key enzymatic co-factors), the presence of a hypermetabolic state, and 
hypoperfusion due to macro- and/or microcirculatory dysfunction, among others 
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(Donnino et al., 2010; Jones and Puskarich, 2009; Trzeciak et al., 2007; James et al., 1999; 
Gore et al., 1996; Rady, 1992).  Liver dysfunction may contribute to both decreased 
clearance and increased production, which becomes even more important in states of 
hypoperfusion. 
 
2.5.5.3 Hyperlactatemia 
 
A plasma lactate level exceeding 4mmol/L is defined as hyperlactatemia, and results 
during conditions where production exceeds utilization. Hyperlactatemia can be 
associated with normal blood pH, acidosis, and alkalosis, and can also be found in 
conditions of normoxia, hypoxia and anoxia (Handy, 2006).  
 
Hyperlactatemia’s pathological causes were historically divided between those with 
evidence of one or another of the well-known causes of hypoxia; and those with no 
detectable disturbance in oxygen transport in the usual sense (Huckabee, 1961). 
According to the Cohen-Woods classification hyperlactatemia may occur (primary/Type 
B) due to an underlying disease process (B1), medication (B2), or an inborn error of 
metabolism (B3), or with (secondary/Type A) decreased tissue perfusion or tissue 
oxygenation (Mizock, 1989), although, many critically ill patients can have 
hyperlactatemia because of both these mechanisms (Phypers, 2006). 
 
a.) Primary (Type B) hyperlactatemia 
 
Hyperlactatemia not associated with poor tissue perfusion is clinically more prevalent (i.e., 
alkalosis or increased metabolic activity).  Often during critical illness, patients have 
continued elevations in lactate production without ongoing evidence of cellular ischemia 
or hypoxia. In such cases, a decrease in pH can be compensated for by body-buffering 
mechanisms (Smith et al., 2001). 
 
Primary hyperlactatemia is caused by increased lactate production which is stimulated 
irrespective of tissue hypoxia, as a response to inflammatory mediators or through other 
mechanisms (Chiolero et al., 2000).  The causes of primary hyperlactatemia are divided, 
into Type B1 (related to underlying diseases), Type B2 (related to the effect of drugs and 
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b.) Secondary (Type A) hyperlactatemia 
 
Secondary hyperlactatemia is caused by tissue hypoperfusion, or when the body-
buffering mechanisms are not able to compensate for the decreasing pH (Smith et al., 
2001; Chiolero et al., 2000).  This type of hyperlactatemia is the most common type of 
hyperlactatemia post cardiac surgery. Secondary hyperlactatemia is frequently caused by 
hypoperfusion and tissue hypoxia that are associated with significant cardiopulmonary 
compromise. Either systemic or regional hypoperfusion may result in hyperlactatemia 
(Mizock and Falk, 1992). The major causes for secondary hyperlactatemia are regional 
hypoperfusion (limb, mesenteric ischemia), shock (cardiogenic, haemorrhagic, 
hypovolemic, or septic), severe anaemia, severe respiratory acidosis (asthma) and severe 
hypoxemia (Juneja et al., 2011; Mizock, 1989). 
 
2.5.5.3.1 Predictive factors for hyperlactatemia 
 
Hyperlactatemia appears in association with peripheral circulatory failure (tachycardia, 
sweating, reduced arterial blood pressure and mental confusion), with low arterial blood 
O2 saturation, and with acid-base disturbances (O’Connor and Fraser, 2010). Dangerous 
hypoperfusion and substantial hyperlactatemia can exist despite the lack of acidosis.  
 
a.) Operative factors contributing to hyperlactatemia 
 
Lactic acidosis is often observed as being related to low output syndrome, hypoxemia and 
cardiac surgery with CPB, which usually show clinical evidence of poor tissue oxygen 
delivery.  Despite evidence of good cardiac output, early postoperative hyperlactatemia 
is seen in some children after surgical repair of CHD.  Severe hypovolemia or cardiac 
arrest triggers anaerobic metabolism and hyperlactatemia, all of which can be pre-, intra- 
or postoperatively due to the many cardiac or resuscitation problems found in paediatric 
CHD patients.  Changes in lactate levels in post-cardiac surgery patients are not 
homogenous in nature, since early hyperlactatemia and late hyperlactatemia differ in 
both risk profile and physiological rationale (O’Connor and Fraser, 2010). 
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i.) Preoperative factors contributing to hyperlactatemia 
 
The electivity/urgency of surgery can influence postoperative lactate levels.  According 
to Maillet et al. (2003) the more elective the surgery, the lower the postoperative blood 
lactate levels.  Urgent or emergency surgery is usually performed on hemodynamically 
unstable patients, therefore, the preoperative lactate values might already be abnormal 
in these patients.  According to Demers et al. (2000) pre-operative risk factors like 
arteriosclerosis, congestive heart failure, and left ventricular ejection fraction less than 
30% was associated with increased lactate levels intra- and postoperative. 
 
ii.) Intra- and postoperative factors contributing to hyperlactatemia 
 
Intraoperatively, CPB has been associated with increased risk of postoperative 
complications and outcomes in both adults and children (Molina-Hazan and Paret, 2014). 
CPB can initiate systemic inflammatory response syndrome (SIRS) that impairs multiple 
organ functions and result in hemodynamic instability and early morbidity in new-borns, 
more so than in infants and children (Roth et al., 2006).  In several previous reports, 
prolonged CPB and aortic cross-clamp times were cited as risk factors for major 
postoperative complications and increased mortality (Gessler et al., 2009; Barach et al., 
2008; Joao and Faria, 2003). Roodpeyma et al. (2013) studied 143 patients that underwent 
CPB, the patients who died had significantly longer CPB and aortic cross-clamp times 
compared to the surviving patients. 
 
Hyperlactatemia occurring early after CPB may be the result of intraoperative or early 
postoperative impaired lactate clearance, tissue oxygen debt, or both (Molina-Hazan and 
Paret, 2014).  It may, however, follow CPB despite a normal perioperative course and well-
maintained oxygen delivery.  The length of CPB and, especially, the episode of hypotension 
at the start of the bypass period appear to be related to the development of lactic acidosis.  
 
Non-pulsatile, hypothermic CPB itself can contribute to the impairment of peripheral 
perfusion thus altering the metabolic balance.  It is linked to the collapse and slugging of 
capillary vessels influenced by the duration of CPB and lactate concentration fluctuations 
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(increase after the commencement of CPB, remaining elevated during CPB, decreasing 
after CPB, and increasing again after surgery) (Molina-Hazan and Paret, 2014). 
 
Lactate levels of 4mmol/L or higher in patients who underwent congenital cardiac surgery 
tend to have a significantly longer CPB time, aortic cross-clamp time, and a decreased 
haemoglobin value (Demers et al., 2000).  The administration and frequent use of 
vasopressors intraoperatively is also associated with the occurrence of postoperative 
hyperlactatemia (Maillet et al., 2003). 
 
During cardiac surgery, the infusion of exogenous D-lactate Ringer’s solution can also 
cause iatrogenic hyperlactatemia in infants with immature liver function (Zhou and Liu, 
2011). 
 
Metabolic disturbances, such as electrolytic composition and blood acid-base balance, 
hyperlactatemia and hyperglycaemia, are factors that frequently complicate the early 
postoperative period in patients after cardiac surgery under extracorporeal circulation.  
Mostly, Hyperlactatemia is seen post-cardiac surgery and a reduction in hepatic lactate 
clearance may contribute to the condition.  Early postoperative measurable side effects, 
such as maximal anion gap, base deficit and bicarbonate levels, were significantly 
different between patients with postoperative hyperlactatemia and patients with low-
normal lactatemia in the early postoperative period (i.e. less than 12 hours after 
admission to ICU) (Abrahams et al., 2010; Chiolero et al., 2000).   
 
Inadequate tissue oxygen delivery because of impaired cardiac output after paediatric 
cardiac surgery is a common problem which can be expressed in the early stages by 
hyperlactatemia, and has been associated with significant morbidity and mortality 
(Chakravarti et al., 2009).  Clinical indicators used for diagnosing decreased cardiac 
output other than hyperlactatemia include; low peripheral temperature/core 
temperature gradient, high pulse and low blood pressure, long capillary refill time, 
decreased urine output and base deficit (Bohn, 2011).  However, most of these indicators 
do not reflect cardiovascular performance very well (Tibby et al., 1997). 
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Average renal and cerebral oxygen saturation (rSO2) levels of less than 65% measured by 
near-infrared spectroscopy (NIRS) predict hyperlactatemia (>3mmol/L) in acyanotic 
children after congenital heart surgery (Chakravarti et al., 2009).  Chakravarti et al. 
(2009) reported that an averaged renal and cerebral rSO2 was a good predictor of lactate 
status, with a value ≥65%, predicting a lactate level ≥3mmol/L, with a sensitivity of 95% 
and a specificity of 83% in the studied patients.  Therefore, monitoring of rSO2 could aid 
in the prompt identification of patients at risk of hyperlactatemia and low-cardiac output 
syndrome (Chakravarti et al., 2009). 
 
Patients with higher blood lactate levels during CPB were also more likely to have 
myocardial infarction and postoperative hemodynamic, pulmonary, neurologic, 
digestive, or renal complications (Demers et al., 2000).  Postoperative episodes of 
hyperglycaemia, hypotension, the use of norepinephrine, epinephrine and dobutamine 
were also more frequently seen in patients with hyperlactatemia following cardiac 
surgery compared to patients with non-elevated blood lactate levels (Maillet et al., 2003).   
 
2.6 Myocardial protection during cardiac surgery 
 
The past century has witnessed the emergence and advancement of techniques to protect 
the heart and allow for the safe conduct of increasingly more complex cardiac surgeries. 
During the last couple of decades, advances in myocardial protection were closely linked 
to strategies designed to provide global organ protection, most notably of the kidneys and 
brain (Bigelow et al., 1950). Myocardial protection is an essential component of cardiac 
surgery, with key principles being the reduction of metabolic activity by hypothermia and 
cessation of mechanical and electrical activity of the heart (Bove et al., 1988; Grice et al., 
1987). These principles remain essential in cardiac surgery of the paediatric population. 
 
The paediatric cardiac surgeon is confronted with hearts in varying stages of maturity. 
This is a significant variation since, as the myocardium matures, fundamental changes 
occur that directly influence the ability of the heart to withstand periods of ischemia and 
injury. The point at which the heart transitions to be more robust is most likely to occur 
during the earlier stages of life and potentially within the first 3 months of life; however, 
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the exact transition point is still debatable (Bove et al., 1988; Grice et al., 1987). In general, 
there is a belief that the normal neonatal myocardium is more resistant to ischemia and 
reperfusion injury than the mature adult myocardium (Bove et al., 1988; Grice et al., 
1987). These differences must be considered when considering the best possible strategy 
for myocardial protection during neonatal and infant cardiac surgery. 
 
2.6.1 Clinical mechanisms of myocardial protection 
 
The most widely practiced methods to ensure myocardial protection during paediatric 
cardiac surgery include: 
 
i) Hypothermia, to reduce metabolic activity during ischemia 
ii) The administration of cardioplegia with potassium as the main ingredient to 
achieve electrical and contractile arrest (Mayer, 1998) 
 
For neonatal and infant cardiac surgery, there is no clear consensus among surgeons 
regarding the optimal strategy for myocardial protection. However, most institutions 
incorporate both hypothermia and the administration of cardioplegia during their 
paediatric cardiac procedures (Mayer, 1998). 
 
2.6.2 Methods providing myocardial protection during cardiac surgery 
 
Hypothermia and cardioplegic arrest can be used to provide myocardial protection 
during cardiac surgery. 
 
2.6.2.1 Hypothermia 
 
A significant amount of myocardial protection can be provided by hypothermia alone and 
may be the single most important factor contributing to myocardial protection during 
neonate and infant cardiac surgery (Doenst et al., 2003; Bull et al., 1984). When cooling 
the human body to 32 degrees Celsius (˚C) total body oxygen consumption is reduced by 
45% (Bigelow et al., 1950). At temperatures below 12˚C the oxygen consumption of the 
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heart is below 1% of what is considered normal and contractile function ceases (Niazi 
and Lewis, 1955). More profound selective myocardial hypothermia is also often used 
during the cross-clamping of the aorta to aid in the preservation of the ischemic 
myocardium (Niazi and Lewis, 1955).  
 
Myocardial hypothermia can be achieved in two ways: by topical application of ice slush 
or cold pericardial lavage, or by coronary perfusion with a cold cardioplegic solution. The 
optimal temperature for myocardial protection is controversial; however, Swanson et al. 
(1980) have demonstrated superior protection at temperatures as low as 2-4˚C, if 
alkalosis is present. The heart is promptly arrested during cooling, and freezing 
temperatures are avoided (Swanson et al., 1980). 
 
2.6.2.2 Cardioplegia 
 
During cardiac surgery, cardioplegia provides an additional level of myocardial 
protection. Cardioplegia is essentially used to induce the cessation of all contractile and 
electrical activity of the heart. Because of the cessation, there is a significant reduction in 
energy consumption, even during normothermia (Buckberg, 1995). Almost all 
cardioplegic solutions exert their protective effects through the hyperpolarization or 
depolarization of the myocardial cell’s membrane and the mechanical arrest of the heart. 
Hyperpolarizing cardioplegic solutions contain high levels of potassium, sodium, and 
magnesium, while depolarizing cardioplegic solutions contain low electrolyte levels 
(Martin and Benk, 2006).  
 
The composition of a cardioplegic solution differs according to the mechanism involved 
during ischemic-reperfusion injury. The mechanisms include; elevated osmotic pressure 
to prevent oedema formation, addition of free radical scavengers, addition of buffering 
agents to reduce acidosis, and the supplementation with substrates to improve energy 
production during the process of rewarming and reperfusion (Allen et al., 2001; Bilfinger 
et al., 1992). 
 
The focus has shifted to the development of cardioplegic solutions directed at prolonging 
the tolerance of the myocardium to ischemia by maintaining the heart in a state of 
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“reversible injury”.  Potassium depolarization arrest through hyperkalaemia has 
developed into the primary component of cardioplegic solutions (Conti et al., 1978). 
Depolarization arrest significantly reduces the metabolic energy demands of myocytes. 
There are indications that normothermic arrest at 37˚C decreases the O2 demands of the 
heart by 90% to 1ml O2/100 gram (g)/minute (Buckberg et al., 1977).  Currently, 
hyperkalaemic cardioplegic solutions are the clinical standard and have an elevated 
potassium concentration ranging between 12 and 25mmol/L.  In cardiac cells, the resting 
membrane potential is around -90mV, these hyperkalaemic solutions lead to membrane 
potential depolarization (-50mV). The sodium channels are also inactivated at this 
membrane potential and the heart is arrested in a flaccid diastolic state (Segurola and 
Kelly, 2004).  However, at this membrane potential, other ionic mechanisms such as 
sodium-hydrogen exchange may cause a slow influx of sodium which could lead to 
calcium overload during reperfusion, which is toxic to the myocardium (Segurola and 
Kelly, 2004). 
 
Even though depolarization arrest has become an essential component of cardioplegia, 
the features of hyperpolarization arrest warrant some consideration.  Hyperpolarization 
arrest maintains the membrane of the myocardium near the resting membrane potential 
(Segurola and Kelly, 2004). There are certain energy dependent processes, such as the 
sarcolemma and sarcoplasmic reticular Na+-K+-ATPase and Ca2+-ATPase pumps, which 
remains active during depolarization arrest (Cohen et al., 1993). 
 
Hyperpolarization causes complete arrest of the sinus node. A key property of 
hyperpolarization is its potassium agonistic property which offers a more complete and 
persistent arrest of the heart than depolarization. This property led to the use of 
hyperpolarizing agents for the induction of cardiac arrest with cardioplegia instead of 
depolarizing agents. A more balanced transmembrane gradient is offered by the 
hyperpolarized state, which maintains ionic balances during ischemia. Polarized arrest 
has been associated with improved recovery of myocardial function and reduced ionic 
imbalance (Segurola and Kelly, 2004).  
 
A hyperpolarized state is possible with the use of several drugs like adenosine, sodium 
channel blockers (lidocaine, procaine, and tetrodotoxin), or potassium channel openers 
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(pinacidil and nicorandil). Reduction of myocardial arrest time and recovery after 
reperfusion is significantly better when using adenosine cardioplegic solutions alone or 
in combination with potassium (Segurola and Kelly, 2004). 
 
For this study emphasis will be placed on St Thomas II cardioplegia and Bretschneider 
custodiol cardioplegia. 
 
i.) St Thomas II cardioplegia 
 
The initial St Thomas’ Hospital cardioplegic solution was first introduced into clinical 
practice at St Thomas’ Hospital, in London, by Braimbridge in 1975 (Chamber and Hearse, 
2001). This cardioplegic solution was later modified to become the St Thomas II 
cardioplegic solution (Chamber and Hearse, 2001), which was approved in the US by the 
Food and Drug Administration (FDA) and was produced commercially as Pegisol. Such 
was the success of this rationalized cardioplegic solution that, within a very short space 
of time, this cardioplegic solution had been accepted for use by most major cardiac 
centres, almost completely replacing the use of coronary perfusion and other procedures 
(Chamber and Hearse, 2001). 
 
St Thomas II cardioplegia is an extracellular cardioplegic solution which contains high 
concentrations of sodium, magnesium and calcium (Geissler and Mehlhorn, 2004) (Table 
2.2). The high calcium content in the solution is to avoid calcium inconsistency during the 
reperfusion phase and to maintain cell membrane integrity. The high magnesium content 
stabilizes the myocardial membrane by inhibiting a myosin phosphorylase which 
protects adenosine triphosphate (ATP) reserved for post ischemic activity. Sodium 
bicarbonate is added prior to use to buffer the St Thomas II solution; rendering the 
solution slightly alkaline thus helping to compensate for metabolic acidosis that 
accompany ischemia (Athanasuleas and Buckberg, 2009).  
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channels or pumps are activated, and metabolic demand on the ventricular myocyte is 
minimal (Cohen et al., 1993). The depletion of sodium in the extracellular space causes 
hyperpolarization of the myocyte plasma membrane, inducing cardiac arrest in diastole. 
This mechanism of action differs from that of conventional ‘extracellular’ cardioplegic 
solutions, which are high in potassium content and cause arrest by depolarizing the 
myocardial cell’s membrane (Chamber, 2003).  
 
The high histidine content of Bretschneider custodiol cardioplegia acts as a buffer for 
acidosis caused by the accumulation of anaerobic metabolites during extended ischemic 
periods. Tryptophan acts by stabilizing the cell membrane, and ketoglutarate acts by 
improving ATP production during reperfusion. Custodiol cardioplegia also contains 
mannitol which acts as a free-radical scavenger and decreases cellular oedema 
(Bretschneider, 1980). Kresh et al. (1987) noted that the histidine protein buffer might 
be superior to bicarbonate in stabilizing intracellular pH and facilitating recovery of post-
ischemic mechanical and biochemical parameters. 
 
Despite the widespread use of Bretschneider custodiol cardioplegia in Europe, there is 
limited data comparing the efficacy of custodiol cardioplegia to other crystalloid 
cardioplegias (Ji et al., 2012; Kim et al., 2011). There is also a lack of data comparing 
Bretschneider custodiol with other solutions for heart preservation during 
transplantation (Ji et al., 2012; Kim et al., 2011). The adequacy of myocardial protection 
offered by only a single dose of cardioplegia is a concern. Concerns have been raised 
about the hyponatremia that follows the rapid administration of the requisite high 
volume of this low sodium cardioplegic solution (Ji et al., 2012; Kim et al., 2011). The 
adverse effects of severe hyponatremia can result in damage to the central nervous 
system and are associated with seizures (Arieff, 1986).  
 
Bretschneider custodiol cardioplegic solution can be improved by the inclusion of 
additional substrates such as aspartate and glutamate. The use of amino acids through 
anaerobic pathways via the infusion of three amino acids (ornithine, aspartate, and 
glutamate) during ischemia augmented the recovery of contractile function in isolated 
rabbit hearts (Rau et al., 1979). 
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2.7 Postoperative complications and outcomes after CPB 
surgery 
 
2.7.1 Postoperative complications 
 
Postoperative complications are defined as any deviation from the ideal postoperative 
course that may or may not be directly related to the disease for which the surgery was 
done or to the surgery itself (Dindo and Clavien, 2008).  The postoperative complications 
and outcomes associated with cardiac surgery are depicted in table 2.4.  
 
Morbidity refers to the diseased state of the patient and may potentially lead to mortality. 
Mortality is the fatal outcome of morbidity (Laffey et al., 2002). In paediatric cardiac 
surgery, it has been shown that higher surgical volume is associated with improved 
survival rate, particularly for high risk surgery (Welke et al., 2009). National benchmark 
data have revealed that overall mortality after congenital heart surgery is <4% at most 
institutions (Agarwal et al., 2014). 
 
Prolonged aortic cross-clamp time is a significant risk factor predicting postoperative 
morbidity and mortality (Bezon et al., 2006). Complex cardiac surgery requiring prolonged 
aortic cross-clamping is associated with high morbidity and mortality from direct damage 
to the myocardium (Rady et al., 1998; Turner et al., 1995). Prolonged aortic cross-
clamping, CBP and DHCA times are associated with cardiac arrest in ICU (Suominen et al., 
2001). This is in line with findings of Rady et al. (1998) in which long aortic cross-clamp 
times (120min) and CPB times (140min) were predictors of postoperative mortality in 
elderly patients. Even in children, prolonged aortic cross-clamp and CPB times have been 
independent predictors of major adverse events during the postoperative phase (Duke et 
al., 1997).  
 
The extent of the inflammatory response to CPB has been associated with preoperative 
conditions such as heart failure and shock (Mou et al., 2002); intraoperative factors such 
as the duration of CPB and cardioplegic arrest (Kirklin et al., 1983) and genetic differences 
(Gaudino et al., 2003; van Deventer, 2000). Several studies have found a relationship 
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cause of postoperative wound infection. Similarly, prolonged duration of aortic cross-
clamp has been associated with high morbidity and mortality rates and prolonged 
mechanical ventilation and ICU stay (Szekely et al., 2006; Davis et al., 2004). 
 
An elevated lactate level >2mmol/L has been associated with an increased risk for 
morbidity and mortality following paediatric cardiac surgery (Kanazawa et al., 2015; 
Basaran et al., 2006; Charpie et al., 2000; Cheifetz et al., 1997; Duke et al., 1997) 
contradicted by Perfecto et al. (2012) and Shime et al. (2001) stating that elevated 
intraoperative lactate levels is associated with increased morbidity and mortality. 
Elevated blood lactate levels were associated with postoperative complications in 
hemodynamically stable surgical patients and a higher mortality rate, and failure of serum 
lactate levels to reach normal values within a specific time during critical illness could be 
even more closely related to survival than the initial level (Meregalli et al., 2004). During 
and post-CPB hyperlactatemia has been linked to increased morbidity and mortality in 
children undergoing surgical repair of complex CHD (Cheung et al., 2005; Munoz et al., 
2000). Several factors contribute to lactic acidosis because of the hypo circulatory state 
during cardiopulmonary resuscitation and the global ischemia occurring during 
circulatory arrest. Oxygen deficiency leads to anaerobic metabolism and therefore to 
overproduction of lactate. At the same time, liver function may be impaired due to the 
profound ischemic state, leading to reduced lactate clearance.  
 
In a prospective study Basaran et al. (2006) included 60 infants undergoing surgery for 
CHD and showed that mortality was higher in the group with a mean lactate of greater 
than 4.8mmol/L in the early postoperative period. Blood lactate levels have been shown 
to be even superior to mixed venous blood saturation in predicting outcome (Duke et al., 
1997). The time it takes for serum lactate levels to reach normal values postoperatively 
is also a useful predictor of mortality in children undergoing repair or palliation of CHD 
under CPB, while initial and peak lactate levels have a poor positive predictive value for 
mortality (Kalyanaraman et al., 2008). 
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2.7.2 Postoperative outcomes 
 
The parameters regarded as postoperative outcomes in this study included inotropic 
support, time of ventilation and ICU stay. 
 
2.7.2.1 Inotropic support 
 
Inadequate pharmacological treatment (inotropes and vasopressors) for low cardiac 
output and reduced oxygen delivery may contribute to multiple organ failure which is 
one of the main causes of prolonged hospital stay and postoperative morbidity and 
mortality (Duranteau et al., 1999).   
 
Myocardial inotropy refers to the intrinsic ability of the myocardial cells to contract 
vigorously.  Therefore, a positive inotropic agent causes an increase in the force of 
myocardial contraction, contributing to the improvement of left ventricular pump 
function, thus improving perfusion to vital organs including the central nervous system, 
kidney and heart (Choudhury and Saxena, 2003).   
 
During paediatric cardiac surgery, maintenance of adequate oxygen balance is one of the 
primary objectives.  Cardiac output (CO) is a major contributor of oxygen delivery so 
maintenance of CO is very important. Therefore, inotropes and vasodilators are used to 
improve cardiac performance after cardiac surgery. 
 
Large multinational randomized controlled trials are still needed to assess the optimal 
use of inotropes and vasopressors. However, some recommendations can be made 
(Lahtinen et al., 2011; Mebazaa et al., 2010; Mebazaa et al., 2004; Duranteau et al., 1999): 
 
a. All catecholamine’s have positive inotropic and chronotropic effects. There is 
evidence that the myocardial oxygen balance is better preserved using 
dobutamine when compared to the other commonly used drugs. Dobutamine 
increases heart rate and stroke volume. Combinations of dobutamine-
norepinephrine are frequently used if blood pressure is low. 
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b. In the case of low blood pressure due to vasoplegia norepinephrine should be used 
to maintain an adequate perfusion pressure and the preload should be regularly 
assessed to avoid hypovolemia caused by vasopressors. 
c. Compared to dobutamine, phosphodiesterase III inhibitors are potent 
vasodilators and cause less tachyarrhythmia. Phosphodiesterase III inhibitors 
have a more favourable effect on the myocardial oxygen balance compared to the 
catecholamine’s. 
 
Recently a calcium sensitizer, levosimendan, has been successfully introduced for the 
treatment of low cardiac output in the perioperative period (Joshi et al., 2016). 
 
Tabib et al. (2016) reported that delayed sternal closure, sepsis, re-intubation, vasoactive 
inotropic score (VIS) and numbers of inotropes used would be independent predictors 
for mechanical ventilation more than 72 hours. 
 
2.7.2.2 Ventilation management 
 
Pulmonary complications are frequently seen postoperatively even in patients with 
healthy lungs. These complications include; diminished functional residual capacity 
(FRC) following muscle relaxants and general anaesthesia, reductions in vital capacity 
(VC) following median sternotomy and intrathoracic manipulation, increased 
intravascular lung water, atelectasis, and increased capillary leakage and extravascular 
lung water due to the inflammatory response to CPB and surgery (Apostolakis et al., 
2010; Kilpatrick and Singer, 2010). Excessive fluid loading and multiple blood product 
transfusions may further compromise lung function. Acute arterial hypoxemia due to 
ventilation-perfusion mismatch and shunting is a result of acute FRC reduction. In the 
early postoperative phase, the primary goals are the restoration of FRC and maintenance 
of adequate gas exchange in the face of rising oxygen consumption (VO2) and the rate of 
carbon dioxide elimination (VCO2), which can be achieved by a lung-protective 
ventilation strategy with adequate levels of Positive End-Expiratory Pressure (PEEP) 
(Apostolakis et al., 2010). 
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There is still an ongoing debate regarding optimal extubation time and window of 
opportunity (Higgins, 1995).  Several studies showed good results on outcome, after 
extubation in the operating room, which makes it feasible (Djaiani et al., 2001; Lee and 
Jacobsohn, 2000). However, about 4hours after CPB the nadir of ventricular function 
occurs. Also, the first few hours after cardiac surgery are characterized by periods of 
hemodynamic instability, increased mediastinal blood loss, temperature dysregulation, 
and other homeostatic disturbances (Van Mastrigt et al., 2006). The deterioration of 
patients can occur rapidly in this early postoperative phase and it is believed that the 
instabilities can be best anticipated and treated in an ICU setting in ventilated and sedated 
patients. Therefore, the window of opportunity for extubation is between 2 and 6hours 
postoperatively (Van Mastrigt et al., 2006). 
 
2.7.2.3 ICU stay 
 
Recent improvements in facilities in paediatric ICU’s have increased the survival rates 
among children suffering from CHDs, including those suffering from the more complex 
conditions (Joao and Faria, 2003). The patient’s course after successful heart surgery 
depends on diverse factors such as the severity of CHD, condition of the patient before 
surgery, patient’s age, events in the operating room, and the quality of postoperative care 
(Bernstein, 2007). In a retrospective study done by Burstein et al. (2011) which included 
20 922 patients, they found that the median length of ICU stay for paediatric cardiac 
patients were 6 days. Paediatrics who undergo an uncomplicated cardiac surgery, with 
good intraoperative care should need little postoperative management for a smooth 
recovery (Backer et al., 2003).  
 
Medical care of cardiac surgical patients in the perioperative setting has for several 
decades consisted of high-dose opioid stress-free anaesthesia and prolonged mechanical 
ventilation in the ICU.  The concepts of fast-track cardiac anaesthesia, early extubation 
and short-stay intensive care have in recent years become the backbone of modern 
perioperative care (Myles and McIlroy, 2005; Hawkes et al., 2003). 
 
Crucial “pre-considered” steps in the development of fast-track cardiac surgery include 
alterations in anaesthetic protocol using short-acting sedative hypnotics and analgesics, 
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less invasive surgical and perfusion techniques, preservation of normothermia, fluid 
restriction, haemostasis management, and the reduction of the inflammatory response 
(Paone et al., 1998). 
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3.3.1 Study cohorts 
 
Objective 1&2: The 96 patients were divided into two cohorts.  Group 1 consisted of 
patients with all peak intraoperative blood lactate values less than 
4mmol/L and group 2, patients with at least one peak intra-operative 
blood lactate value equal or higher than 4mmol/L. 
 
Sub-objective: The 96 patients were divided according to the cardioplegic solution 
received during corrective cardiac surgery.  Group 1 consisted of 
patients that received St Thomas II cardioplegic solution and group 2, 
patients that received Bretschneider custodiol cardioplegic solution. 
 
3.3.2 In- and exclusion criteria 
 
To address the objectives and sub-objective of the study, the selection criteria for the 
patients were based on two main variables namely they must present with a confirmed 
congenital heart defect and the need to undergo corrective congenital cardiac surgery. 
The specific requirements for the inclusion and exclusion of patients in this study are 
outlined in the inclusion and exclusion criteria below. 
 
3.3.2.1 Inclusion criteria 
 
Participants were included in the study if they met the following criteria: 
 
i. Paediatric patients aged 0-12 years 
ii. Patients diagnosed with CHD 
iii. Patients that received CPB, hypothermia (≤32°C) during surgery, with the use 
of either St Thomas II or Bretschneider custodiol cardioplegia solution 
iv. Aortic cross-clamp time >90 minutes 
v. A baseline preoperative lactate value of <2mmol/L 
vi. Complete patient (data) files 
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3.3.2.2 Exclusion criteria 
 
The following participants were excluded from the study: 
 
i. Patients older than 12 years of age 
ii. Patients not presenting with CHD 
iii. Patients that received off-pump cardiac surgery with hypothermia (≥32°C), 
patients that did not receive St Thomas II or Bretschneider custodiol 
cardioplegic solution 
iv. Aortic cross-clamp time <90 minutes 
v. A baseline preoperative lactate value of >2mmol/L 
vi. Incomplete patient (data) files 
 
3.4 Study design 
 
The study was a retrospective analytical cohort including paediatric patients presenting 
with congenital heart defects who underwent CPB surgery between 2012 and 2014. 
 
3.5 Conceptual framework for data collection 
 
The data was collected according to the conceptual framework summarized in Figure 3.1 
and Figure 3.2. 
 
3.5.1 Objective 1 and 2 – Lactate <4mmol/L versus ≥4mmol/L 
 
Group 1 consisted of patients with peak intraoperative blood lactate values less than 
4mmol/L and group 2, patients with peak intraoperative lactate values equal or higher 
than 4mmol/L.  Prior to CPB surgery (hypothermia ≤32˚C) the patient’s demographic 
data (age, gender, weight, height, body surface area (BSA), and ethnicity) clinical data 
(type of CHD lesion) and preoperative metabolic data (lactate and Hct) were recorded.  
During CPB, arterial blood gas (ABG) analysis was done after the initiation of bypass and 
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every 15 minutes thereafter, until the termination of CPB.  From the ABG’s the peak 
intraoperative lactate and Hct were recorded.  Oesophageal temperature was also 
recorded.  Additionally, the type of cardioplegia used (St Thomas II or Bretschneider 
custodiol), aortic cross-clamp time and total bypass time were recorded. 
 
Postoperatively, the patients’ lactate and Hct values were recorded upon admission to 
ICU and 24h, 48h, and 72h thereafter. 
 
The STS database was used to document the postoperative complications (cardiac arrest, 
arrhythmia, heart block, low cardiac output, acidosis, pericardial effusion requiring 
drainage, pulmonary hypertension, pneumothorax, pleural effusion requiring drainage, 
pneumonia, chylothorax, tracheostomy, phrenic or recurrent laryngeal nerve injury, 
respiratory insufficiency requiring mechanical ventilation >7 days postoperatively or 
reintubation, transient or permanent neurologic deficit, new onset seizures, 
wound/sternal dehiscence, infection/SIRS, endocarditis, acute renal failure, sternum left 
open, bleeding requiring reoperation).  The postoperative outcomes recorded for both 
groups included; the time of inotropic support, time spent on a ventilator, ICU stay and 
mortality (Figure 3.1). 
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3.5.2 Sub-objective – St Thomas II versus Bretschneider custodiol cardioplegia 
 
CPS 1 consisted of patients that received St Thomas II cardioplegia solution, and CPS 2, 
patients that received Bretschneider custodiol cardioplegia solution.  Prior to CPB 
surgery (hypothermia ≤32˚C) the patient’s demographic data (age, gender, weight, 
height, body surface area (BSA), and ethnicity) clinical data (type of CHD lesion) and 
preoperative metabolic data (lactate, Hct, K+ and Na+) were recorded.  During CPB ABG 
analysis was done after the initiation of bypass and every 15 minutes thereafter, until the 
termination of CPB.  From the ABG’s the peak intraoperative lactate, Hct, K+ and Na+ were 
recorded.  Additionally, the aortic cross-clamp time, total bypass time and oesophageal 
temperature (°C) were recorded.  
 
Postoperatively, the patient’s lactate, Hct, K+ and Na+ were recorded upon admission to 
ICU and 24h, 48h, and 72h thereafter. 
 
The STS database was used to document the postoperative complications (cardiac arrest, 
arrhythmia, heart block, low cardiac output, acidosis, pericardial effusion requiring 
drainage, pulmonary hypertension, pneumothorax, pleural effusion requiring drainage, 
pneumonia, chylothorax, tracheostomy, phrenic or recurrent laryngeal nerve injury, 
respiratory insufficiency requiring mechanical ventilation >7 days postoperatively or 
reintubation, transient or permanent neurologic deficit, new onset seizures, 
wound/sternal dehiscence, infection/SIRS, endocarditis, acute renal failure, sternum left 
open, bleeding requiring reoperation,). In addition to the postoperative complications, 
postoperative outcomes were recoded; the time of inotropic support, time spent on a 
ventilator, ICU stay and mortality. 
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3.6 Special investigations 
 
Demographic, clinical, intraoperative and postoperative data were recorded for each 
patient that met the inclusion criteria of the study.  All the data were sourced from the 
patients’ medical files. 
 
3.6.1 Preoperative data 
 
The following demographic and clinical data were recorded for each participant prior to 
surgery: 
 
• Age (months/years) 
• Gender (male/female) 
• Ethnicity (black/white/indian/coloured) 
• Weight (kg) 
• Height (cm) 
• BSA (m2) 
• Type of CHD lesion 
 
3.6.2 Intraoperative data 
 
3.6.2.1 Metabolic data 
 
In theatre but prior to surgery, one millilitre of whole blood was drawn in a pre-
heparinized syringe for ABG analysis.  The blood was drawn from an indwelling radial 
artery catheter after induction of anaesthesia (preoperative baseline values).  
 
During CPB, blood was drawn from the sample port of the oxygenator after the initiation 
of bypass and every 15 minutes thereafter until termination of CPB.  The following 
metabolic data were recorded from the ABG analysis: 
 
• Lactate (mmol/L) 
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i.) St Thomas II cardioplegia solution 
 
• 1000ml St Thomas II cardioplegia solution (Ref: SXA3024, Adcock Ingram 
Critical Care (PTY) Ltd, Johannesburg, RSA). 
• 10ml 8.5% Sodium Bicarbonate (Intramed Sodium Bicarbonate Injection 8.5% 
(50ml) m/v, Ref: FSS850050, Fresenius Kabi for Bodene (PTY) Ltd trading as 
Intramed, Port Elisabeth, RSA). 
 
ii.) Bretschneider custodiol cardioplegia solution 
 
• 1000ml Bretschneider custodiol cardioplegia solution (Ref: Custodiol®, Dr. F. 
Köhler Chemie, Alsbach, Germany). 
 
3.6.2.3 Cardiopulmonary bypass (CPB) surgery 
 
All the patients included in this study underwent CPB surgery and had an aortic cross-
clamp time exceeding 90 minutes. Table 3.2 is a summary of the surgical procedure. 
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3.6.3.2 Postoperative clinical outcomes and complications 
 
The clinical outcomes and complications recorded for each patient were based on the STS 
database as outlined (Society of Thoracic Surgeons, 2011) in Figure 3.1. 
 
3.7 Statistical analysis 
 
The statistical analyses were performed by a qualified biostatistician.  Data were 
captured electronically by the researcher using Microsoft Excel.  Statistical analyses were 
done with R software [R version 3.2.2 (2015-08-14), Copyright © 2015. The R 
Foundation for Statistical Computing, International Standard Book Number (ISBN) 3-
900051-07-0, Platform: x86_64-pc-mingw32/x64 (64-bit)]. R is an open source 
programming language and software environment for statistical computing and graphics, 
t-tests and the calculation of confidence intervals were done with XLSTAT (XLSTAT 
Version 2016.03.30846).  Data and results generated with R and XLSTAT and, where 
possible, validated with Microsoft ® Excel ® 2013 (Microsoft Corporation, Redmond, 
US). 
 
Normally distributed continuous data was expressed as means and standard deviations, 
not-normally distributed data as medians and percentiles, and categorical data as 
frequencies and percentages.  Data was compared using Student’s t-test for normally 
distributed continuous variables, the Mann-Whitney test for continuous data that was not 
normally distributed and the 2 or Fisher’s exact 2 test for categorical variables. 
 
3.8 Ethical aspects and good clinical practice 
 
3.8.1 Ethical clearance 
 
The study only commenced after ethical approval was granted by the Ethics committee 
of the University of the Free State (ECUFS NR 241/2015) (Appendix A). 
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3.8.2 Good clinical practice (GCP) / quality assurance 
 
All clinical work conducted during this research project was subjected to the good clinical 
practice guidelines.  The Declaration of Helsinki’s basic principle number 3, states that 
research should be conducted only by scientifically qualified people and under the 
supervision of adequately qualified personnel involved (South African Good Clinical 
Practice guidelines, 2006; World Medical Association Declaration of Helsinki, 2013). 
Fundamentally GCP requires oversight of the local ethics committee, verification of the 
investigator’s qualifications, a study protocol, informed consent and essential 
documentation needed to undertake the study, monitoring, submission of reports and 
maintenance of records.  The application of GCP guidelines in this research study 
provides public assurance that the rights, safety and well-being of the participants are 
protected and that the research data are credible. 
 
3.8.3 Confidentiality 
 
Personal details of patients participating in this study were kept confidential, as far as 
possible.  At no time during the research were the identity of patients revealed to persons 
not part of the research team.  During the study, patients were identified by their hospital 
number (e.g. RXH 123 456 789), thus preventing the disclosure of the patient’s personal 
details and ensuring patient confidentiality at all times. 
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4mmol/L was chosen as the cut-off value to select a group of patients with predicted 
postoperative adverse clinical outcomes after undergoing CPB for the repair of congenital 
cardiac lesions. 
 
This study aimed to answer the following questions: 
 
• Is a peak intraoperative lactate value of 4mmol/L associated with a higher 
incidence of postoperative complications and clinical outcomes in CHD patients 
receiving CPB surgery? 
• Can the use of cardioplegia (St Thomas II or Bretschneider custodiol) be 
associated with an increased incidence of postoperative complications and clinical 
outcomes in CHD patients receiving CPB surgery? 
 
5.2 Peak intraoperative lactate <4mmol/L (group 1) versus 
peak intraoperative lactate ≥4mmol/L (group 2) 
 
5.2.1 Preoperative demographics, anthropometrics and cardiac lesions 
 
Ninety-six (96) paediatric cardiac patients that met the inclusion criteria were divided 
into two groups based on their peak intraoperative lactate values (group 1, n=52 and 
group 2, n=44).  The patients in group 2 were much younger (median 2.4 months, range 
0.097-181 months) compared to the patients in group 1 (median 14.5 months, range 1-
157 months) at the time of cardiac surgery.  A statistical significant difference was 
recorded for age (0.0438) between the two (2) groups, which is just below the 0.05 
significant limit. 
 
The two groups were comparable with regard to anthropometric variables (p>0.05).  
Both groups showed a female preponderance (52% vs 55%) with most patients being 
coloured (52% vs 55%). 
 
The two groups included a similar spread of cardiac lesions except in group 1 most 
patients were treated for an AVSD (19%) and in group 2, TGA (34%). 
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5.2.2 Metabolic data 
 
5.2.2.1 Lactate (mmol/L) 
 
Preoperatively both groups had similar mean lactate levels (1.23mmol/L vs 
1.07mmol/L).  No patient with a preoperative lactate value exceeding 2mmol/L were 
considered for this study.  Intraoperatively, the peak lactate levels did differ significantly 
(p<0.0001) but could be expected based on the criteria used to create the patient cohorts. 
 
The reasons for the increase in lactate values during CPB can possible be explained by: 
 
• During CPB pulsatile flow is converted to laminar flow patterns contributing to 
peripheral vasoconstriction and decreased peripheral tissue energy production.  
Furthermore, hypoperfusion of the intestinal mucosa stimulates the divergence of 
O2 away from the splanchnic vascular bed, resulting in raised hepatic lactate 
production (Pojar et al., 2008; Chiolero et al., 2000). 
• In addition, peripheral vasoconstriction associated with CPB causes the 
redistribution of circulating volume to the vital organs, compromising the 
microcirculation.  This phenomenon is associated with peripheral arteriovenous 
shunting resulting in decreased perfusion to the skeletal muscles, which are an 
important lactate oxidizer.  If decreased perfusion to the skeletal muscles persist 
it might result in serum lactate production (Trzeciak et al., 2005; Chiolero et al., 
2000). 
• During CPB, haemodilution reduces perfusion pressure and reduces the O2 
carrying capacity of blood.  Therefore, in combination with the leftward shift of O2 
haemoglobin dissociation induced by hypothermia, this might limit O2 delivery to 
the cells (Scaravilli et al., 2012). 
• Hypothermia during CPB also contributes to vasoconstriction leading to further 
hypoperfusion at microcirculatory level and decreased splanchnic perfusion. 
 
All the derangements stated above may contribute to increased lactate levels during CPB 
even in the presence of normal oxygenation and circulation (Jones et al., 2009).  
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From ICU admission till 48hr postoperatively, group 2 presented with significantly higher 
mean lactate values compared to group 1.  Although at 48hr both groups had mean lactate 
levels less than 2mmol/L.  These findings are supported by Kliegel et al (2004) concluding 
that if hyperlactatemia persists beyond 48 hours it seemed to be a predictor of poor 
outcome.  With decreased splanchnic circulation and peripheral tissue/muscle perfusion, 
a build-up of lactate in the tissue occurs.  During the postoperative period, a washout of 
lactate tends to occur.  Postoperatively all the factors contributing to decreased blood 
flow to non-vital organs are eliminated as the patient is returned to normothermic 
temperatures and pulsatile flow is restored, which allows for peripheral tissue and gut 
mucosa to be perfused again returning lactate levels to normal. 
 
5.2.2.2 Haematocrit (%) 
 
Haematocrit is a marker of haemoconcentration and blood viscosity, especially in 
children.  In many cases, especially in paediatrics, hypovolemia and secondary 
haemoconcentration play a significant role in disturbed microcirculation (Marics et al., 
2015).  No statistical differences were seen between the two groups preoperatively, 
intraoperatively or postoperatively.  The lowest mean haematocrit values were recorded 
intraoperatively for both groups (group 1, 27.71%; group 2, 26.64%).  This could be 
attributed to haemodilution caused by the priming of the heart-lung machine circuit and 
the administration of cardioplegia (Ranucci et al., 2006).  Similar findings were reported 
by Abrahams et al., (2010). 
 
5.2.3 Aortic cross-clamp time (min), CPB time (min) and oesophageal 
temperature (°C) 
 
Both the aortic cross-clamp time (group 1, mean 125.3min, range 78-212min; group 2, 
mean 144.5min, range 99-261min; p=0.0106) and CPB time (group 1, mean 178.1min, 
range 102-342min; group 2, mean 221.4min, range 119-418min, p=0007) were longer in 
group 2 and showed a statistical significant difference when compared to group 1.  This 
suggests that high blood lactate levels are more likely to occur with longer aortic cross-
clamp and CPB times but are still dependent on other pre- and intraoperative factors.  
Similar results were reported by Demers et al. (2000), patients with lactate levels of 
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4mmol/L or higher had significantly longer CPB times and aortic cross-clamp times.  
Furthermore, an association was found between the duration of CPB and the magnitude 
of hyperlactatemia in the early postoperative period by Bakanov et al. (2009). 
 
Both groups were cooled down intraoperatively therefore reflecting low oesophageal 
temperatures (group 1, mean 28°C, range 19.7-32°C; group 2 mean 25.5°C, range 18.8-
32°C).  A weak statistical significant difference was reported between the 2 groups with 
group 2 reflecting lower mean oesophageal temperatures (p=0045). 
 
5.2.4 Postoperative complications and clinical outcomes 
 
Postoperative complications were reported for both group 1 and 2 but only 
wound/sternal dehiscence (group 1, 3.8%; group 2, 20.5%; p=0.0208) and sternum left 
open (group 1, 11.5%; group 2, 34.1%; p=0.0157) showed statistical significant 
differences between the two (2) groups. Özker et al. (2012) stated that delayed sternal 
closure after cardiac surgery is a therapeutic option in the treatment of severely impaired 
heart in paediatric cardiac surgery. Postoperative wound infection and the severity 
thereof ranges from a superficial wound infection (which involves only skin or 
subcutaneous tissue) to fulminate mediastinitis with subsequent involvement of the 
sternum (sternal dehiscence and osteomyelitis) and organ tissues outside the incision 
(Mangram et al., 1999). Several reasons could contribute to the development of 
wound/sternal dehiscence in children e.g. children with asplenia or had a cardiac 
transplant, those requiring β-adrenergic drugs, obstructive respiratory problems, 
concomitant infections at other sites and poor tissue oxygenation on the site of injury 
(Tortoriello et al., 2003).  
 
Postoperative complications that showed high recorded percentages for both lactate 
groups were acidosis (group 1, 28.8%; group 2, 34.1%), infection/SIRS (group 1, 46.2%; 
group 2, 63.6%) and acute renal failure (group 1, 23.1%; group 2, 22.7%). 
 
Morbidity associated with CPB, also referred to as “post-pump syndrome” ranges from 
mild capillary leakage followed by intravascular volume depletion, generalized oedema, 
circulatory compromise, altered microcirculation and ultimately multi organ system 
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failure (Durandy, 2014; Warren et al., 2009; Siegel et al., 1996).  The occurrence of “post-
pump syndrome’ has been attributed to the exposure of blood cells to foreign surfaces 
(CPB circuit) thus initiating the release of inflammatory mediators that may further 
contribute to lung, myocardium, kidney, liver, intestine and brain impairment (Durandy, 
2014; Warren et al., 2009).   
 
The acidosis seen in both group 1 and 2 could be secondary to tissue hypoperfusion, 
which occurs despite the use of hypothermia to reduce metabolic demands and the 
maintenance of normal mixed venous oxygen saturations during CPB (Siegel et al., 1996).  
SIRS is a frequent complication observed in children after open-heart surgery and has 
been associated with both CPB and surgical trauma (Boehne et al., 2017).  A higher 
incidence of SIRS is also reported with younger age or lower body weight (Guvener et al., 
2015; Soares et al., 2010).  According to literature the occurrence of acute kidney failure 
after paediatric open-heart surgery varies from 1.6% to 52%.  This corresponds with our 
results as cardiac surgery with CPB is commonly perceived as a risk factor for decline in 
renal function (Krastins et al., 2012). 
 
No statistical significant differences were reported between group 1 and 2 for inotropic 
support time (p=0.2434), intubation time (p=0.1604), number of days spend in ICU 
(p=0.1646) and mortality (p=0.6805).  Similar results were found by Lindsay et al. 
(2013).  However, patients in group 2 experienced longer need for inotropic support 
(mean±SD 137.4±92 vs 106.7±150.2). The SD is extremely high in both groups therefore 
if you look at the median values for group 1 it is 76.5 vs 94.0 in group 2. The longer need 
for inotropic support in group 2 also had a longer intubation time (mean 95.2min vs 
70.3min) and the remained longer in ICU (8.96 days vs 6.8 days) compared to the patients 
in group 1.  The mortality rate in group 2 (18%) was also higher when compared to group 
1 (14%). The longer need for inotropic support in group 2 could be ascribed to prolonged 
aortic cross-clamp, reperfusion injury, myocardial stunning, technical problems during 
surgery, cardioplegia and pre-existing congestive cardiac failure. Furthermore, 
pulmonary hypertension is a frequent problem encountered by paediatric patients 
suffering from CHD. Patients with pulmonary hypertension can develop right ventricular 
dysfunction due to an increase in the afterload of the right ventricle. In this situation 
pulmonary vasodilators or inotropes with pulmonary vasodilating properties 
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(inodilators) are frequently used to facilitate separation from CPB (Choudhury and 
Saxena, 2003). 
 
The peak intraoperative lactate cut-off value of 4mmol/L may be too low to show an 
association between hyperlactatemia and postoperative complications and clinical 
outcomes.  Furthermore, it might be of more value to evaluate the time that the patient 
was exposed to the elevated lactate levels rather than looking at a single peak 
intraoperative lactate value.  In our practice, persistent high levels of lactate 
intraoperatively (>2.5mmol/L) prompts therapeutic intervention to increase tissue 
perfusion both intra- and postoperatively.  The therapeutic intervention reduces the time 
that the patient is exposed to elevated lactate levels and may be the reason why an 
association could not be made between postoperative complications and outcomes and 
high intraoperative lactate levels (≥4mmol/L).  In this study, the sample size was small, 
and a larger study population could bring forward differences not possible to show with 
relatively small numbers of patients. 
 
5.2.5 Cardioplegic solutions 
 
During the study two (2) different types of cardioplegic solutions were administered 
based on the preference of the cardiothoracic surgeon performing the open-heart 
surgery.  In group 1 most patients received St Thomas II cardioplegia (75%, n=39) and in 
group 2 most patients received Bretschneider custodiol cardioplegic solution (55%, 
n=24).  A statistical significant difference was recorded between the two (2) groups with 
regard to the cardioplegic solution used (p=0.0036). 
 
Bretschneider custodiol cardioplegia is used by some centres for myocardial protection 
in complex cardiac surgeries as well as for organ preservation in transplant surgery.  This 
type of cardioplegia is attractive for cardiac surgeons because it is administered as a 
single dose and is claimed to offer myocardial protection for up to three (3) hours 
(Gebhard et al., 1984; Bretschneider, 1980), allowing performance of complex 
procedures without interruption (Edelman et al., 2013).  On the other hand, St Thomas II 
cardioplegic solution has also been a popular cardioplegic solution among cardiac 
surgeons but must be administered repeatedly at short intervals during surgery.  An 
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increase in myocardial acidosis between the dosages have been reported, affecting 
postoperative outcome adversely (Khuri et al., 2005; Graffigna et al., 2002). 
 
Most patients that received Bretschneider custodiol cardioplegia presented with the 
cardiac lesion, transposition of the great arteries (55%, n=22) and most patients that 
received St Thomas II cardioplegia presented with an AVSD (19%, n=10).  Therefore, for 
the more complex and longer surgeries Bretschneider custodiol cardioplegia was used. 
 
To summarize, in this study patients presenting with peak intraoperative lactate levels of 
4mmol/L or higher in general did not display more postoperative complications or 
poorer clinical outcomes when compared to patients with peak intraoperative lactate 
values of <4mmol/L. 
 
5.3 St Thomas II versus Bretschneider custodiol cardioplegia 
 
The ninety-six (96) patients were then divided based on the cardioplegic solution used 
during cardiac surgery irrespective of their intraoperative lactate values.  Two (2) 
cohorts were created, CPS 1 (patients receiving St Thomas II cardioplegia, n=59) and CPS 
2 (patients receiving Bretschneider custodiol cardioplegic solution, n=37) and the 
demographic, anthropometric, cardiac lesions, intraoperative and postoperative 
complications and outcomes were compared between the two (2) groups. 
 
5.3.1 Preoperative demographics, anthropometrics and cardiac lesions 
 
The patients receiving Bretschneider custodiol cardioplegia (CPS 2) were younger 
(median 8.35 months’ vs 19.00 months) weigh less (median 6.24kg vs 8.30kg) and were 
shorter (median 50.00cm vs 76.00cm) compared to the patients receiving St Thomas II 
cardioplegia (CPS 1).  All these variables showed statistical significant differences 
between the two (2) groups (p<0.05).  In both CPS groups, most patients were female 
(CPS 1, 54%; CPS 2, 51%) coloured (CPS 1, 51%: CPS 2, 57%) patients. 
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The predominant cardiac lesions in CPS 1 were AVSD (n=12, 20%) and in CPS 2, TGAs 
(n=20, 54%).  From these results it seemed that Bretschneider custodial cardioplegia was 
the cardioplegia of choice when performing more complex cardiac surgeries that usually 
requires longer bypass times. 
 
5.3.2 Metabolic data 
 
5.3.2.1 Lactate (mmol/L) 
 
Intraoperatively, both CPS groups showed an increase in serum lactate values from 
baseline.  The mean intraoperative lactate value for CPS 1 was 3.28mmol/L and for CPS 
2 was 4.21mmol/L, showing a statistical significant difference between the groups 
(p=0.0332).  Upon admission to ICU, the mean lactate values of both CPS groups already 
started to decrease (2.80mmol/L vs 3.40mmol/L) and gradually decreased further till 
both groups reported a mean lactate value below 2mmol/L at 48hr postoperatively 
(1.37mmol/L vs. 1.61mmol/L).   
 
Cardioplegic arrest and CPB during cardiac surgery are associated with ischemic/hypoxic 
stress seen in cardiac and non-cardiac tissues as previously explained.  A consequence of 
ischemic/hypoxic stress (anaerobic metabolism) associated with cardioplegic arrest and 
CPB is the accumulation of lactate in cardiac as well as peripheral and visceral tissues 
(Ascione and Angelini, 2003).  Therefore, the intraoperative increase in lactate in this 
study is likely to be due in part to myocardial (and probably pulmonary) lactate that had 
accumulated during the cardioplegic arrest and CPB.  However, limited literature is 
available about changes in blood lactate levels in children with CHD receiving cardiac 
surgery with CPB.  Bretschneider custodiol cardioplegia is supposed to provide good 
buffering capacity and enhances anaerobic energy production during ischemic 
cardioplegic arrest (Ackemann et al., 2002; Morishita, 1999). 
 
Furthermore, evidence suggests that hyperlactatemia observed following cardiac surgery 
may correlate with the duration of CPB (Inoue et al., 2001).  In this study patients 
receiving Bretschneider custodiol cardioplegia had a much longer bypass time (mean 
215.38min) than the patients receiving St Thomas II solution (mean 186.95min). 
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5.3.2.2 Haematocrit (%) 
 
The haematocrit values showed no statistical significant differences (p>0.05) between 
CPS 1 and CPS 2 for any of the recorded time points.  Intraoperatively, a decrease in the 
mean haematocrit values were recorded for both groups from baseline (CPS1, baseline 
37.97%, intraoperative 26.76%; CPS 2, baseline 40.46%, intraoperative 27.95%).  As 
previously explained the reason for the decrease could be attributed to haemodilution 
caused by the priming of the heart-lung machine circuit and the administration of 
cardioplegia (Ranucci et al., 2006). 
 
5.3.2.3 Sodium (mmol/L) 
 
The mean sodium values irrespective of the cardioplegic solution used, recorded 
intraoperatively (CPS 1, 133.63mmol/L; CPS2, 126.89mmol/L) fell outside the normal 
range of 135-145mmol/L (https://www.ucsfbenioffchildrens.org/tests/003481.html).  
The mean sodium values differ statistically between CPS 1 and CPS 2 intraoperatively 
(CPS 1, 133.63mmol/L; CPS2, 126.89mmol/L; p<0.0001) and after CPB upon admission 
to ICU (CPS 1, 139.58mmol/L; CPS 2, 137.41; p=0.0108).  In both cases lower sodium 
values were recorded for patients that received Bretschneider custodiol cardioplegic 
solution (CPS 2). St Thomas II cardioplegia is an extracellular crystalloid cardioplegia and 
have sodium and calcium concentrations that mimics the concentrations found in plasma, 
whereas intracellular solutions, such as Bretschneider custodiol, have low sodium and 
calcium concentrations to mimic the intracellular milieu (Kotani et al., 2013).  Therefore, 
Bretschneider custodiol solution can cause hyponatremia and haemodilution because of 
its low sodium concentration (15mmol/L) and relatively large volume of administration 
(50mL/kg) if it is drawn into the CPB circuit.  When considering small intravascular and 
CPB priming volume, the risk of acute hyponatremia and normalization may be increased 
in paediatric patients (Kim et al., 2011). 
 
As in this study, Lindner et al. (2012) and Kim et al. (2011) also reported that 
hyponatremia was more frequently seen in the paediatric population after the 
administration of intracellular cardioplegic solutions. 
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The sodium values recorded at the other time-points were comparable between the 
groups with no statistical significant differences (p>0.05). 
 
5.3.2.4 Potassium (mmol/L) 
 
The potassium values at all the recorded time points for both CPS 1 and CPS 2 fell within 
the normal reference range of 3.5-5.5mmol/L and in considerable young or premature 
infants as high as 6.5mmol/L (Verive, 2016).  A rise in intraoperative potassium levels 
was seen for both St Thomas II (Pre-CPB, 4.04mmol/L, Intra-CPB-low 5.11mmol/L) and 
Bretschneider custodiol cardioplegic solution (Pre-CPB, 4.02mmol/L, Intra-CPB-low 
5.04mmol/L). The only statistical difference in mean potassium values between CPS 1 
and CPS 2 was recorded 24hr (CPS 1, 4.80mmol/L; CPS 2, 4.35mmol/L; p=0.0005) and 
72hr (CPS 1, 3.95mmol/L; CPS 2, 4.28mmol/L; p=0.0492) post-CPB, however, although 
there are statistical differences between the two groups the results remain within the 
normal reference range.   
 
St Thomas II cardioplegic solution has a low sodium ion concentration.  Low extracellular 
sodium concentration leads to cardiac arrest by depriving substrate for the fast sodium 
upstroke of the action potential, supported by a slight elevation of the extracellular 
potassium concentration (Gebhard et al., 1983) preventing further myocardial cell 
swelling by reducing sodium-potassium exchange pump activity during hypothermia 
(Shaffer et al., 1998).  In a study conducted by Aldemir et al., 2014 they also reported a 
rise in potassium intraoperatively (4.39mmol/L) just after the unclamping of the aorta 
and even speculated that the higher serum potassium levels just after unclamping of the 
aorta was a favoured condition for lower ventricular fibrillation incidence. 
 
5.3.3 Aortic cross-clamp (min), CPB time (min) and oesophageal temperature 
(°C) 
 
In both CPS groups, the mean aortic cross-clamp time (CPS 1, 129.90min; CPS 2, 
140.86min) and oesophageal temperature (CPS 1, 27.44°C; CPS 2, 25.87°C) were similar, 
and these variables were not statistically different between the two (2) groups (p>0.05).  
However, a statistical significant difference was seen between CPS 1 and CPS 2 for the 
© Central University of Technology, Free State
 94 Discussion 
total bypass time (p=0.0328).  Patients receiving Bretschneider custodiol cardioplegia 
(215.38min) had a much longer mean bypass time than the patients receiving St Thomas 
II cardioplegia (186.95min). 
 
The statistical significance in bypass time between the two (2) CPS groups could be that 
Bretschneider custodiol cardioplegia was preferred by surgeons performing more 
complex surgeries.  Most patients that received Bretschneider custodiol cardioplegia had 
TGAs (34%) whilst most patients receiving St Thomas II cardioplegia solution presented 
with AVSDs (20%).  According to Vianna et al. (2013) a single-dose cardioplegia may be 
an attractive option in more complex cardiac procedures as re-administration of 
cardioplegia can disturb the technical flow of the operation. 
 
5.3.4 Postoperative complications and clinical outcomes 
 
No statistical significant differences were calculated for any of the postoperative 
complications or clinical outcome variables between the CPS 1 and CPS 2 groups except 
for phrenic or recurrent laryngeal nerve (RLN) injury (p=0.0199) and new onset seizures 
(p=0.0199).  Patients receiving Bretschneider custodiol cardioplegia had a higher 
incidence of both phrenic or recurrent laryngeal nerve injury (10.8% vs 0.0%) and new 
onset seizures (10.8% vs 0.0%) compared to the children that received St Thomas II 
cardioplegic solution. 
Nerve injuries after thoracic and cardiovascular surgery generally involve the brachial 
plexus, phrenic nerve, recurrent laryngeal, and facial nerve.  Nerve injuries can also be 
the result of increased procedure duration causing prolonged periods of nerve 
compression (Setty et al., 2014).  In this study, both the aortic cross-clamp time 
(140.86min vs 129.90min) and the total bypass time (215.38min vs 186.95min) were 
longer in the CPS 2 group that presented with the nerve damage.   
 
Injury to the RLN can be a severe complication in cardiac surgery because it causes airway 
compromise by vocal cord paralysis (VCP) also referred to as cardiovocal syndrome 
(Alfares et al., 2016).  The incidence of VCP following cardiac surgery ranges widely from 
1.7% to 67% (Dewan et al., 2012), however, most studies indicate the rate is less than 9% 
that corresponds well with the 10.8% (CPS 2) recorded in this study.  Infants, weighing 
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less than 1500g, are premature or younger, also have a higher risk of developing RLN 
paralysis (Mulpuru et al., 2008).  In this study, a statistical significant difference was 
recorded for both weight (p<0.0004) and age (p<0.0001) between the two (2) CPS groups 
with the CPS 2 group being much younger and weighing much less than the CPS 1 group. 
 
The two most common mechanisms of injury are direct trauma either to the recurrent 
laryngeal nerve (RLN) during the operation or indirect injury to the nerve from 
intubation (Otani et al., 1998).  Aside from direct injury eight (8) mechanisms for RLN 
injury has been identified: central venous catheterization, hyperextension of the neck, 
traumatic endotracheal intubation, endotracheal tube trauma, faulty insertion of the 
nasogastric tube, sternotomy, traction on the heart, and hypothermic injury from ice 
slush (Hamdan et al., 2002).  Furthermore, higher rates of RLN injury is also indicated 
during aortic arch procedures, due to the proximity to the surgical plane of dissection 
(Dewan et al., 2012).   
 
Phrenic nerve injury results in paralysis of the diaphragm and impairs respiratory 
function. According to Mok et al. (1991) phrenic nerve paralysis causes severe 
respiratory embarrassment in neonates but seems to cause fewer clinical or physiological 
abnormalities in children more than one (1) year old, unless associated respiratory 
muscles is compromised.  In this study, the children that presented with increased 
phrenic and RLN injury (CPS 2) were much younger (median age 8.35 months) compared 
to the children with no incidence (CPS 1) (median age 19.00 months).  The children in the 
CPS 2 group also experienced more respiratory insufficiency requiring mechanical 
ventilation >7 days postoperatively or reintubation (32.4%) compared to the children in 
the CPS 1 group (16.9%).  This could be the reason why the children in the CPS 2 group 
were longer intubated (mean 91.8hr vs 75.7hr) and remained longer in ICU (8.3 days’ vs 
7.4 days) compared to the children in CPS 1.  However, note that these variables were not 
statistically significant between the two (2) groups. 
 
New onset seizures after paediatric cardiac operations have been described by several 
authors (Kim et al., 2011; Hsia et al., 2006; Bellinger et al., 1995).  Bretschneider custodiol 
cardioplegia is known for its low sodium concentrations (15mmol/L) and relatively large 
administration volume (50mL/kg) and can therefore cause both hyponatremia and 
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haemodilution.  Hyponatremia can lead to seizures in children and during anaesthesia 
can cause cerebral oedema and can affect the blood-brain barrier (Castilla-Guerra et al., 
2006).  Furthermore, the abrupt normalization of hyponatremia can cause even more 
detrimental effects on the central nervous system (McManus et al., 1995).  All the children 
that presented with new onset seizures in this study received Bretschneider custodiol 
cardioplegia (CPS 2). 
 
The clinical outcomes showed no statistical differences for inotropic support (p=0.7532), 
intubation times (p=0.5417), length of ICU stay (p=0.3845) and mortality (p>0.9999) 
between the patients that received Bretschneider custodiol cardioplegia and those 
receiving St Thomas II cardioplegia (p>0.05).  These results were confirmed by literature 
(Di Eusanio et al., 2013; Gaudino et al., 2013; Shrestha et al., 2014; Viana et al., 2013; 
Braathen et al., 2011; Scrascia et al., 2011; Demmy et al., 2008; Martin et al., 2008; 
Salvador et al., 2008; Minami et al., 2005; Wiesenack et al., 2004; Careaga et al., 2001; 
Beyersdorf et al., 1990; Gallandat Huet et al., 1988). 
 
Therefore, in this study patients receiving Bretschneider custodiol cardioplegia 
presented with phrenic and recurrent laryngeal nerve damage and new onset seizures 
that is not seen in patients receiving St Thomas II cardioplegia.  For any of the other 
postoperative variables recorded no differences were seen when comparing CPS 1 with 
CPS 2. 
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
